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ABSTRACT
Consumption of high salt leads to the alteration of vascular p-adrenoceptor response
which subsequently modifies the blood vesse l responses. This change could be due to an
alteration in p-adrenoceptor-mediated signalling in blood vesse ls. To test this hypothesis,
an evaluation of p-adrenoceptor-mediated mechanical and electrical responses was
undertaken in low-pr essure segment of the circulatory system i.e. main pulmonary
arteries, of Sprague-Dawley rats fed either normal or high salt diets for 18-23 days.
Blood pressure and heart rate were monitored in anesthetised rats using intra-arterial
catheters. Isometric tension was measured in isolated pulmonary artery ring preparations.
Glass microelectrodes were used for the recording of membran e potential (Em)'
Consumption of high salt resulted in a modest increase in blood pressure but not heart
rate. Isoprenaline evoked hyperpolarization in pulmonary arteries of rats fed a normal
diet. Hyperpolarization evoked by stimulation of p-adrenoceptor involved multiple
processes including the activation of K+channels and Na+/K+ATPase.
The remova l of endothelium produced hyperpolarization of vascular smooth muscle cells
in blood vessels obtained from rats fed a normal diet. The hyperpolarisation due to
denudation was the result of the activation of K+channels and Na+/K+ATPase. Moreover,
hyperpolarization as a consequence of p-adrenoceptor stimulation appeared to be
mutually dependent on the presence of endothelial cells since this event (i.e.
hyperpolarization) as evoked by isoprenaline was absent in denuded tissues.
Isoprenaline-mediated relaxation was found to be partly dependent on the presence of
endothelium.
Isoprenaline produced similar relaxations in intact pulmonary arteries obtained from
animals fed a high salt compared to normal diet. However, the £", was found to be more
negative in intact pulmonary arteries of animals fed a high salt diet compared to those fed
a normal diet. The isoprenaline evoked hyperpolarization was notably absent in the
pulmonary arteries. In addition, in intact versus denuded blood vesse ls obtained from rats
on high salt diet, the £", was not significantly different.
Taken together, the data suggests that the presence of the endothelium is essential for the
propagation of p-adrenoc eptor-m ediated relaxation . Moreover, the evidence seems to
also imply that consumption of high salt leads to the activation ofK+channels and
Na+/K+ATPase channels preserving p-adrenocept or-mediated relaxations in pulmonary
arteries.
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1.0. INTRODUCTION
1.1. Overv iew of cardiovascular system
The cardiovasc ular system is one of the integral components of the body that helps in
maintaining cellular homeostasis. It includes the heart and blood vessels (Guyton and
Hall, 2000; Tortora and Grabowski, 2010). The heart pumps blood and blood vessels
channel and deliver it throughout the body. Arteries carry blood saturated with oxygen
and nutrients away from the heart to all parts of the body. Arteries are thick-walled tubes
with a circular coverin g of yellow, elastic fibres, which contain a filling of muscle that
absorbs the tremendou s pressure wave of a heartbeat and slows the blood down (Guyton
and Hall, 2000; Tortora and Grabowski, 2010). This pressure can be felt in the arm and
wrist and is referred to as the pulse. Eventually, arteries divide into smaller arterioles and
then into even smaller capillaries, the smallest of all blood vesse ls. One arteriole can
serve a hundred capillaries. Here, in every tissue of every organ, capillary exchange takes
place where cells take up oxygen and nutrients and send away the waste products.
Capillaries jo in together to form small veins called venules, which flow into larger main
veins, and these deliver deoxygenated blood back to the heart. Veins, unlike arteries,
have thin, high distensible walls, because the blood has lost the pressure which forced it
out of the heart , so the deoxygenated blood which flows through the veins on its way to
the lungs moves along very slowly on its way to be reoxygenated. From the right side
heart, deoxygenated blood flows to the lung via unique vessels i.e. pulmon ary arteries to
be oxygenated, and then back to the left side of heart to begin its journe y around the body
once again . The blood vessels consist of various cells types that communi cate with each
other in response to physio logical stimuli to maintain adequate blood flow in the
circulatory system (Guyton and Hall, 2000; Tortora and Grabowski, 2010) .
1.2. Blood vessels
The blood vesse ls of the card iovascu lar system are divided into arteries, arterio les,
capillaries, venules and veins . The vascular wall is made up of three layers or tunics of
three different cells (Pugsley and Tabrizchi, 2000) . Start ing from the lumen, the first
layer (tunica internaJintima) is composed of an epithelial cell lining also referred as
endothelium, middle layer (tunica media) consists of smooth muscle cells and connective
tissue, and the outermos t layer (tunica externa) is made up of connective tissue and
contains nerve supply to the blood vessels. The composition of the blood vessel layers
varies in struct ure in correlation to the difference in function that occurs throughout the
cardiovascular system (Guyton and Hall, 2000; Pugsley and Tabrizchi, 2000; Tortora and
Grabowski,2010).
In the cardiovasc ular system , pulmonary arteries in contrast to systemic arteries have
lesser smooth muscle cell layers under normal conditions, consistent with low pressure
system (Daly and Hebb, 1966). The pulmonary vascular resistance is offered by the small
arteries with an internal diameter of a few hundred urn. The pulmonary capillary bed
responds differently from the systemic capillary bed. Pulmonary veins are similar in
structure to pulmonary arteries with less layers of smoot h muscle cells and may be
regulated different ly (Daly and Hebb, 1966). The structure of pulmonary arteries may
change with an increase in pressure, i.e. pulmonary hypertension . The chronic increase in
pressure leads to structural remodelling of the medial layer (increase in number or size of
smooth muscle cells) along with fibrosis (Barer et al., 1989). This change may manifests
alteration in various functional mechanisms involved in the regulation of pulmonary
artery (Barnes and Liu, 1995).
1.2.1. Sympathetic innervations of blood vessels
The sympathetic nervous system modifies blood flow under physiological conditions and
may be involved in the pathophysiology of vascular diseases (Dzau et al., 1994). In
blood vessels, smooth muscle cells are innervated by postganglionic sympathetic nerves.
The density of innervation varies widely from vessel to vesse l. The postganglionic
sympathetic nerve terminals form a network of unmyelinated slender processes that
widen at regular intervals into varicosities (Thaemert, 1966). In most blood vessels, a
plexus of branch ing varicose axons sits in the adventitial layer of blood vesse ls. The
blood vessels with multiple smooth muscle cell layers have direct contact with axons at
the medio-adventiti al border. In addition, branchin g of the axons has also been observed
in the two to three outer layers of the tunica media (Burnstock , 1986). These varicosities
are arranged in series along the length of axon and are separated by narrow intervaricose
regions. The nerve varicosities are irregularly distributed along the axons and the
distance between individual varicosities ranges from almost nothing to >7 urn (Luff et al.,
1987). Generally, varicosities are fusiform shape with variable sizes ranging from 0.4-3.0
urn in diameter and 0.25-4 .0 urn in length (Luff et al., 1987). Other than cell organelles
like mitochondria and sarcoplasmic reticulum; sympathetic nerve varicos ities also have a
number of vesicles that contains a "cocktail" of neurotransmitters. Further these are
classifie d into three different types that include large dense cored vesicles (LDVs), small
dense cored vesicles (SDVs) and small clear vesicles (SCVs) (Stjar ne, 1989). Both SDVs
and LDVs have been shown to store noradrenaline and adenosine triphosphate (ATP)
(LDVs contain 8-20 times more than SDVs), and some LDVs contain neuropep tides
(neuropeptide Y, substance P, Calcitonin gene related peptide) (Stja rne, 1989).
Following stimulation of sympathetic nerves these transmitters are released in the
sympathetic neurovascular juncti ons, the width of which range from 50-100 nm (Luff et
al., 1987) and interact with membrane receptors such as adrenergic (a -, p-adrenoceptors),
purinoceptors result ing in vascular contraction and relaxation.
1.2.1.1. Sympathetic nerve stimulation of blood vessels
The sympathetic nerve stimulation has been linked to depolarization of vascular smooth
muscle cells of guinea-pig pulmonary artery & vein and mesenteric veins (Suzuki, 1981,
1983; Van HeIden, 1988, 1991). The nerve mediated depolarization consists of two
components a) transient one, which occurs at the beginning of the response and; b) a
sustained phase that appears thereafter. Both of these components are blocked by a-
adrenoceptor antagonists. Van HeIden (1991) had reported an ongoing discharge in
mesenteric vein, referred to as a spontaneous transient depolarization. Following, the
nerve stimulation these spontaneous transient depolarizations increase in frequency with a
time lag of 1-2 seconds. Moreover, these high frequenc y spontaneous transient
depolarizations summate to generate a slow excitatory junctional potential. Interestingly,
these spontaneous transient depolarizations are not produced due to transmitter released
from sympathetic nerve terminala but are generated from the irregular oscillating release
of Ca2+ from the internal stores that might as well activate contractile proteins in the
vascular smooth muscle cells (Van Heiden 1991). Collectively, this would suggest that a -
adrenoceptors play an important role in vascular contraction by releasing Ca2+from
internal stores that might cause depolarization of vascular smooth muscle cells.
The membrane potential changes in response to sympathetic nerve stimulation vary in
arteries and veins. A single sympathetic nerve stimulus evokes a membrane
depolarization that is referred to as excitatory jun ctional potential (e.j. p.). Severa l e.j.ps
summate to induce depolarization of a few mV that will activate voltage sensitive Ca2+
channels and this then leads to the contraction of smooth muscle cells (Hirst and
Edwards, 1989). These rapid nerve responses are resistant to inhibiti on by a-
adrenocep tor antagonists (Angus et al., 1988). In arteriolar smooth muscle cells, e.j.ps
are observed that have short latencies of 10-20 ms (Hirst and Neild, 1978; Hirst and
Edwards, 1989). The time course of e.j. ps is faster in neuronal or skeletal synapses than
those recorded from any other autonomic organ tissue (Hirst and Edwards , 1989). The
rapid onset of the response sugges ts that the sympathetic transmitter is activating a
ligand-gated channels and the decay phase reflects a slow rate of closure of such
channels. There is ample amount of evidence to support the idea that e.j.ps in arterioles
and arteries result from the release of ATP and the activation of purinoceptors (P2X)
(Suzuki, 1985; Hirst and Jobling, 1989). In addition, it has been demonstrated that non
selective channels activated by ATP in vascular smooth muscle cells also show high
selectivity for Ca2+ions (Benham, 1989). Altogether, evidence sugges ts that sympathetic
nerve stimulat ion induce s e.j. ps and leads to depolarization via the action of the co-
transmitter, ATP, on cation permeable ligand gated ion channels (P2X receptors) (North,
2002).
Sympathetic nerve stimulation has been linked to an increase in the pulmonary vascular
resistance (Pace et al., 1972; Piene, 1976). Adrenergic innervation of pulmonary
vasculature largely varies amongst mammal s (Richardson, 1979). Histochemical
examination revea led that catecholamine containing nerve fibres are generally absent in
intra-pulmonary artery of rat (El-Bermani , 1978; McLean et al., 1985). Whereas, extra-
pulmonary arteries are abundant in sympathetic innervati on but the extent and density
varies between the specie s (Richardson, 1979). Interestingly, the pulmonary trunk of rat
pulmonary artery is well innervated and produces noticeabl e contraction following
stimulation of nerve. However, the nerve stimulated contraction s are barely detectable in
rat main pulmonary arteries, which suggest that the sympathetic innervation become
scarce further along the pulmon ary vascular tree (Duggan et al., 20 11). Stimulation of
sympathetic nervous system to the pulmonary artery seems to cause stiffening of the
pulmonary vascular bed. This in tum can aid in the propul sion of blood into lungs,
especially in a state of low cardiac output. This hypothesis has been supported by in vivo
investigations conducted in dog and cat pulmon ary artery (Pace et al., 1972; Piene 1976).
1.3. Vascular contracti on
In order to modulate blood flow, numerous endogenous agents act on blood vessels in
response to physiological and pathophysiological stimuli. In blood vesse ls, the
maintenanc e of resting ionic gradient is a fundamental property of the vascular cells that
facilitates propagation and transmission of messages by electrical conduction (Hirst and
Edward, 1989). Modulation of the electrical properties of smooth muscle cells leads to
generation of force, referred to as electromechanical coupl ing. Although spike generation
is involved in triggering contraction, tension may be regulated by depolarization of
quiescent smooth muscle that does not generate action potentials (Su et al., 1964). It is
also clear that contraction can occur by processes that are independent of cell
depolarization and that have been referred to as pharmacomechanical coupling (Su et al.,
1964; Somlyo and Somlyo, 1968; Casteels, 1980; Baron et al., 1984).
Pharmacomechanical responses are elicited by agonist-induced changes in the
concentration of second messenger molecules such as intracellular concentration of Ca2+
([Ca2+] i) , inositol I,4,5-triphosphate (lP3), 1,2 diacylglycerol (DAO) . Invascular smooth
muscle cells, neurotransmitter or autacoids produce contraction through elevation of
[Ca2+]i via Ca2+influx and release of Ca2+ from intracellular stores (such as sarcop lasmic
reticulum). An increase in [Ca2+] i is known to cause smooth muscle contractio n. The
neurotransmitters released by sympathetic nerve stimulation can increase [Ca2+]i in
smooth muscle cells by activating post-juncti onal membrane receptors such as a-
adrenoceptors or purinoceptors. The c-adrenocep tors are guanine-protein-coupled
receptors (OPC R) that increase Ca2+ by releasing Ca2+ from internal stores via the Oaq/
phospholipase C (PLC)/ inositol phosphates (lP)/IP3 pathway (Hirst and Edward, 1989;
Van Heiden, 1991). The purinoceptors are linked to non selective cation channels which
cause depolarization of the membrane resulting in ci+influx via voltage-gated Ca2+
channels (Figure 1) (Sneddon and Burnstock, 1984; Hirst and Edward , 1989).
1.3.1. Vascular smooth muscle cells
The vascular smooth muscle cells are uni-nucleated, non striated muscle cells. They
appear thickest in the middle and taper at each end (Torto ra and Grabows ki, 2010). Like
striated muscle, smooth muscle also contains actin and myosin filaments that play an
integral role in vascular contraction and relaxation. The absence of regular alignment of
filaments into a sarcomere gives the muscle tissue a smooth appearance under the
microscope (Somlyo and Somlyo, 1968). In various blood vesse ls, smooth muscle cells
communicate with each other and endothelial cells via hemi-channels known as gap
jun ctions (Figueroa and Duling, 2009; Dora, 20 10).
The diverse cellular functions of vascular smooth muscle are mediated by complex
interactions between membrane proteins (receptors, ion-channels, ion exchangers) and
intracellular components/systems (sarcoplasmic reticulum, second messengers, contractile
proteins) (Somlyo and Somlyo, 1970).
1.3.1.1. Receptors
The site of interaction of endogenous and/o r exogenous chemica l mediators with the
surface of the cell leading to a response is known as a receptor (Rang and Dale, 2007).
The binding of chem ica l med iators to receptors initiates the intrace llular chemical
cascade . The cellular respo nses to receptor activation vary conside rably according to the
structure and nature of the receptor. There are four different types of recep tor activated
signal transduction. These include guanine-nucleo tide binding protein (G-prote in)
coupled receptors, nucl ear receptors, tyrosine-link ed kinase receptor system and receptor
coupled to ion channels (Rang and Dale, 2007)
GPCRs are the largest class of cell surface receptor super-family. The GPCRs were
named for their ability to associa te with heterotrimeric G-proteins (Gapy) (Gil man, 1987).
These G-proteins function as interme diaries between extrace llular receptors and
intrace llular effectors proteins for a variety of neurot ransmitters and hormones, thus
controlli ng intrace llular conce ntrations of signa l molecu les such as cyclic nucleotides,
Ca2+and IP (Gilman , 1987; Casey and Gilman, 1988). The GPCR is a bund le of seven-
transmembra ne a -helices alternative ly connected through intrace llular and extracellular
loops. The amino terminal (N-terminal) part of the receptor is located on the extracell ular
side of the cytoplasmic memb rane, whereas its carboxy l terminal (C-terminal) faces the
cytoplasm. Heterotrim eric G proteins are comp osed of a, pand y-subunits. The p- and 't:
subunit are considered to be a single functional complex (Gpy), because they do not
dissociate in non-d enaturing conditi ons. The a -subunit can bind and hydrolyze guanosine
triphosp hate (GTP) . They are called heterotrimeric because of the three different subunits
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and G-proteins because they display highly selective binding affinity for guanine
nucleotides. In the basal state, an a -subunit is bound to guanosine diphosphate (GOP)
and is assoc iated with the py complex. Followi ng receptor-ligand binding, the GPCR
undergoes a conformational change such that it prom otes the exchange of GOP for GTP
on the a-subunit. In the GTP-bound state, the a-s ubunit dissociates from the py-comp lex,
and both the a-subunit and the py-compl ex can interac t with and regulate dow nstream
effectors to evoke physiological responses. However, the hydrolysis of GTP associa ted
with the a-s ubunit result s in its re-association with the py complex, leading to the
dissipation of the intracellul ar response (Neer and Clapham, 1988 ; Neer, 1994). There
are severa l other levels of regulation for this system, such as regulators of G-protei n
signall ing (RGS), activa tors of G-protein signalling (AGS) , and G-protein receptor
kinases (GRKs) (Vogler et al., 2008) . The RGS proteins are known to increase the
intrinsic GTPase activity of the a -subunit; AGS proteins activate G-prote ins independent
of GPCR-mediated signa lling, and GRKs phosphorylate key residues on the GPCR,
leading to desensitization and/or endocy tosis of the receptor (Ferguson, 200 1; Sato et al.,
2006) . There are approx imately twenty Gu-subunits known to date. They are divided
into four major Gusubfamilies such as Gas, GUi, Guq/11and GUI2!13 (Hubbard and Hepler,
2006; Plagge et al., 2008). Stimulatory Gasand inhibitory GUi exist as distinct entit ies,
with Gus being responsible for activating the adenylyl cyclase (AC) and Guiinhibi ting the
enzyme and stimulating potassium channels (Gilman, 1987 ; Brown and Birnbaum er,
1988). The Guq/ll is coupled to the activa tion of phospholip ase C-p (PLC- P). Further,
activation of PLC-P leads to the hydrolysis of phosphatidylinositol 4, 5-bisphosphate
(PIP2) and the produ ction of IP3 and DAG. The signalling via this pathway evokes
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responses that are mediated through Ca2+ and protein kinase C (PKC) (Lape tina, 1987;
Hubbard and Hepler, 2006). These mechanisms for receptor-effector coupling are
applicable to a gamut of vascular smooth muscle receptor systems such as adrenergic (a ,
P), muscarinic (M), purinergic (P2) and prostaglandins (PGh and PGE2) .
The nuclear receptors are intracellular receptors that transduce signals from
glucocorticoids, mineralocorticoids, the sex steroids (estrogen, progesterone, and
androgen), thyroid hormones, and vitamin 03 . They are characterized by a central ONA-
binding domain, which targets the receptor to specific ONA sequences known as response
elements (Berg, 1989; Zilliacus et al., 1995). Glucocorticoids, mineralocorticoids,
estrogen and peroxisome proliferator-activated receptor gamma have been shown to play
an important role in cardiovasc ular and metabolic diseases by regulating vascular smooth
muscle migration, proli feration, perivascular inflammation and ultimately contractility to
endogenous mediators such noradrenaline (Walker, 2007; Ketsawatsomkron et al., 20 10).
Tyrosine-linked kinase receptors are characterised by ligand-stimul ated
autophosphorylation of tyrosine kinase that is intrinsic to the receptor (Hunter and
Cooper, 1985). Unlike G-protein receptors, tyrosine-linked kinase receptors consist ofa
single polypeptide containing one hydrophobic region that forms a single transmembrane
domain. The extracellular surface of the receptor encompasses an agonist recognition site
and the intracellular surface incorporates a tyrosine kinase enzyme. The ligands for these
receptors include: platelet-derived growth factor (pO GF), epidermal growth factor
(EGF), transformin g growth factor (TGF), fibroblastic growth factor (FGF) , insulin like
growth factor I (lGF) and atrial natriuretic peptide (ANP). POGF promotes mitogenesis
and is a potent vasoconstrictor. Mechanical stress (myogenic constriction) and vascular
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remodelling due to hypertension has also been linked to activation of tyrosi ne
phosphorylation pathways (Zou et al., 1998; Murphy et al., 2002) . Activation of
Angiotensin II type I receptors induce growth promoting factors via EGF. This cross-ta lk
between growth factors by G-protein couple receptors is known as trans-activation
mechanism (Eguchi and Inagami, 2000; Kalmes et al., 2001).
The group of transmembrane ion channels that are regulated by the bindin g of a ligand
referred to as ligand gated ion channels or receptor-coupled ion channels. These
complexes are all pentameric, comprised of five similar subunits, which form a barrel-like
structure with a channel pore running through the middle of the complex (Large, 2002).
The receptor-coupled to ion channels upon interaction with ligand results in opening of
transmembrane ion channels allowing the flux of cations or anions down their
concentration gradient. This transduction mechanism may or may not be dependent on
intracellular second messengers and the response to agonist bindi ng is faster than that of
biochemical transduction. These ionotropic receptors play a major role in vascular tone
(Gibson et al., 1998; Large, 2002). Members for this family are Na+ channels and
cholinergic nicotinic receptor s.
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1.3.2. Electrical properties of vascular cells
The smooth muscle cells of blood vessels maintain large ionic gradients across their
plasma membranes (Bolton, 1979; Hirst and Edwards, 1989). The asymmetric
distribut ion of ions across the membrane of vascular smooth muscle cells generates the
potential difference known as the resting membrane potential. The ability of vascular
cells to respond to changes in their ionic environment and maintain a relatively constant
internal milieu is one of their most fundamental properties. In response to external
perturbations, cells will activate specific membrane bound ion transport systems in an
effort to maintain overall homeostasis (Bolton, 1979; Hirst and Edwards, 1989).
The concentration gradients for different ions (K+, Cl', Ca2+and Na+)have been estimated
for arterial smooth muscle cells and are listed in Table I (Hirst and Edwards, 1989). The
electrical properties of vascular smooth muscle have been studied extensively in various
tissues amongst various vertebrates. Various studies suggest that the membranes of
vascular smooth muscle are more permeable to K+ ions compared to other ions (Bolton,
1979; Kuriyama et al., 1982; Hirst and Edwards, 1989). This higher permeability to K+
ions results in a resting membrane potential of vascular smooth muscle cells between -55
to -75 mV (Hirst and Edward, 1989; Nelson et al., 1990). Ionic differences are tightly
regulated by membrane proteins such as K+channels, Ca2+channels, cr channels,
electrogenic pump s and various ion-exchangers.
The membrane potential (Em)as given by the Goldman-Hodgkin-Katz equation
(Goldman, 1943; Hodgkin and Katz, 1949):
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Where Emis the membrane potential as determined by the Nemst potential (EK, ENa and
EC/)and the relative conductances of the ions. Individual E»calculated by the Nemst
equation mentioned arc in Table I. For example :
EK= RT/F In [K] J[K]; at 37°C.
Tablel.
Intracellul ar [X] , and extrace llular [X], ion concentration; and equilibrium Nerns t
potential (Ep) of vasc ular smooth muscle cells (Hirst and Edwards, 1989)
Ions IX!i(mM) [X!o(mM) Ep(mV)
Sodium (Na+) 10- 20 - 150 +50
Potassium (K+) 130 -1 60 3 -5 -90
Chloride (Cl") 40 -70 - 140 -20
Calcium (Ca2+) 1O-6 _ 1O-8 M - 2 >+150
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1.3.2.1. The electrogenic pump (Na+/K+ATPase)
The Na+/K+ATPase is a membr ane bound protein that estab lishes and mai ntains high
internal K+ and low internal Na+ concentrations in the smoo th muscle cells (Skou, 2004).
It is an oligomer compose d of a- , p- and y-subunits (Co llins et al., 1982; Mercer et al.,
1993). The a-s ubunit is responsible for the catalytic and ion tran sport pro pert ies of the
enzy me. The p-subun it contains the bind ing sites for the cations, AT P, and the inhibi tor ,
ouabain. The y-subunit is a regulatory subunit and responsibl e for the normal activity of
the enzyme. The latter subunit appea rs to be involved in the occlus ion of K+ by
modul atin g K+ and Na+ af finity of the enzyme. During eac h active cycle th ree Na+ions
are pump ed out of the ce ll in exc hange for two inflow ing K+ ions for eac h ATP mo lecu le
consumed, which impl ies that the enzyme compl ex contains multipl e bind ing sites for
Na+ and K+ (Swead ner, 1989). This exc hange of cations plays a cr itica l role in regulating
the Na+ electroc hemica l gradient across the mem brane. In various ce lls, the Na+
electroc hemica l gradie nt regulates var ious cellular ion counter transporters (Na +/Ca 2+,
Na+JH+/Cr/HC03' , Na+JH+) and co-transporters (Na ' zsuga r/amino acids , Na+/C r ,
Na+/K+/Cn (Mo bas heri et al., 2000). Inhibiti on of the electroge nic pump with ouabain
increases the intracellul ar concent ration of'Na", thu s decreasing its electroc hemica l
gradient that leads to an increase in cytoso lic Ca2+ concent rat ion (Juh aszova and
Blaustein, 1997). The increase in intracellul ar Ca2+ in vascular smoo th mu scle co uld
initiate di fferent signal tran sduction mechanisms that af fect vasc ular myogenic responses
of the circulatory sys tem (Dav is and Hill, 1999; Blaustein et al., 2009).
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1.3.2.2. K+ Channels
The membr anous spanning prot eins that selectively allow K+ ions to pass thro ugh their
pores are known as K+ channels. The K+ channels are the most widely distributed ionic
channels in the body. In the vascular sys tem, these pro teins contribute to regulat ing the
restin g membr ane potenti al, hence vas cular tone of the circul atory sys tem. Effl ux ofK+
ions due to the opening of K+ channels result s in membr ane hyperpolari zation in vasc ular
smoo th muscle. This hyperpolarization leads to the closure of voltage- de penden t Ca2+
channels, and subsequently reducti on in Ca2+ entry , thu s vaso dilation (Ne lson and
Quayle, 1995). On the other hand , inhib ition of K+ channels leads to membrane
depolarization and vasoco nstriction (Ne lson and Quayle, 1995). Four major classes of
potassium channels have been ident ified in vasc ular smoot h muscle; these incl ude
voltage -ga ted potassium channe ls (Kc), inwardly rec tifying potass ium channels (Ks) ,
calcium-act ivated potassium channels (Ke.) and AT P-se nsitive K+ channels (KATP)
(Nelso n and Quay le, 1995; Standen and Quayle, 1998; Ko et al., 2008) . Molecular
biology along with electrophys iolog ical techniques introdu ced another class of K+
channels, i.e. the two pore dom ain potassium channel (K2P)(Lo tshaw , 2007; Enyedi and
Cz irjak G, 20 10).
Voltage-gated potassium channels (K; channels) : K, are ubiquitously ex presse d in
vasc ular smoo th muscle cells (Ne lson and Quay le, 1995). The K, has six transmemb rane
spanning domain s made up of hydrophobic amino acids (SI-S6) , link ed by seq uences of
hydrophil ic amino ac ids . Each subunit also has a cytoplasmic amino- and carboxy-
term inal domain. One of the memb rane-spann ing domains in eac h sub unit (the S4 region)
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is charged , having a basic amino acid (lysine or arginine) every third residue that acts as a
voltage sensor to regulate the function of the channel (Korovki na and England, 2002) .
Each channel has two subunits, a and p. Structurally, a -subunits in K, have cytop lasmic
N- and C-termini and contain a pore. Further, each a-subunit is associa ted with ancillary
p-subunits, which influences the characteristics of the channel (Bahring et al. , 2001 ;
Korovkina and England, 2002). The opening of K, in response to a change in voltage, i.e.
depolarization, results in repolarization and thus return to the resting membrane potential.
The small-scale depolarization in vascular smooth muscle cells leads to an influx of Ca2+
via L-type Ca2+ channels and activation of the contractile machin ery. Taken together, this
suggests that K, function as a buffer and limit membrane depolarization, thus maintain
resting vascular tone (Nelson and Quayle, 1995; Korovkina and England, 2002 ; Ko et al.,
2008). Prolonged depolarization leads to the inactivation of the K, channel. Compared to
the process of activation, K, channel inactivation is relatively slow and involves an initial
peak in the K, current due to voltage-dependent activatio n followed by a drop in the
current due to voltage dependent inactivation (Nelson and Quayle, 1995). The compound
4-aminopyridine (4-AP) has been used in many studies of vascular smooth muscle as a K,
channel blocker (Smirnov and Aaronson, 1992; Nelson and Quayle, 1995). In addition,
tetraethylammonium ion (TEA) also inhibits Kv, although at higher concentrations than
needed to inhibit KCa channels (Robertson and Nelson, 1994).
Inwardly rectify ing potassium channel (K;r): An ion channel that passes K+(pos itive
charge) more easi ly into the cell (inward direction) is known as inward rectifying. The
inward rectifin g K+channels contain tetrameric subunits, each of which consist of only
two transmembrane domains and are encoded by a member of the Kir gene family
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(Standen and Quayle, 1998; Kubo et al., 2005) . In blood vesse ls, Kir2channels exhibit
strong inward rectifi cation (Park et al., 2008). Bradley et al. (1998) have reported mRNA
and protein express ion of Kir2.J, but not Kir2.2 or Kir2.3, in coronary, mesentery and cerebra l
(basilar) arteries of Sprague-Dawley rats. There is a genera l agreement that K; channels
are abundant in the smooth muscle of small-diameter resistance vessels (Knot et al.,
1996; Park et al., 2008; Ko et al., 2008). However, Tennant and co lleagues (2006) have
also identifi ed Kir2.1in cultur ed human pulm onary artery smoo th muscle cells. The
vasc ular smooth muscle K, channels mediat e inward currents at membran e potentials that
are negative relative to the EK and small outward currents at memb rane potentials that are
positive relative to the EK (Park et al., 2008; Ko et al., 2008). Ba2+ ions block Kir2.1in
arterial smoo th muscle cells. The inhibition by BaH ions is amplified at more negative
memb rane potenti als (Robertson et al., 1996; Kubo et al., 2005; Park et al., 2008; Ko et
al.,2 008). The Kir2.1channels play an integral role in K+ induced vasodilation. A local
increase in extracellular K+ in the range of 6- 15 mM has been shown to produce
vasod ilation and pronoun ced hyperpolarization of rat portal vein, mesenteric, coronary
and cerebral arteries in the absence or presence of endothelium (Robertson et al., 1996;
Knot et al., 1996; Edwards et al., 1998; Weston et al., 2002) . The hyperpolarization
induced by high ext racellular K+ ions involved Kir2\ and electroge nic pump
(Na+/K+ATPase) .
Ca2+-activated po tass ium channels (KccJ: On the basis of their conductance, Kca
ramifi ed into three subtypes that includ e large (BKca), intermediat e (IKca) and small
conductance (SKCa) (Nelson and Quayle, 1995). The BKca channels seemed to be
preferent ially expresse d in vasc ular smooth muscle cells, while IKca and SKcaare
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preferentially located in endothelial cells (Ghatta et al., 2006; Feletou, 2009; Grgic et al.,
2009). As the name sugges ts, these K+channels are regulated by the cytoplasmic
concentration ofCaz+. Like K, channels, BKca also buffers pressure- or chemical-
induced depolarization and vasoconstriction by hyperpolarizing the membrane potential
(Tanaka et al., 2004; Ledoux et aI., 2006) . The BKcachannels are comprised ofa pore-
forming a-subunit and regulatory p-subuni t. The pore forming a-subunits contain six
transmembrane-spanning domains (S I-S6) that include a voltage sensor (S4) (Nelson and
Quayle, 1995, Ledoux et al., 2006). An additional seventh transmembrane region (SO)at
the exoplasmic NHz terminu s of BKca has also been reported. The p-subunits enhance
the Caz+sensitivity of the channel (Nelson and Quayle, 1995; Ko et al., 2008) . The BKca
induces vasodilatory responses through the cAMP/PKA or NO/cGMP/PKG pathway.
Treatment with TEA , iberiotoxin, and charybdotoxin blocks the vascular BKcachannels
(Nelson and Quayle, 1995). Of these blockers, iberiotox in is the most selective blocker
of the BKca. Charybdotox in has also been used as a selective BKca channel blocker;
however, it also affects IKca (Ko et aI., 2008). Potential activators of BKcaare NS1619,
NS 1608 and estrogen (Ledoux el al., 2006) .
A TP-sensilive potass ium channels (KATP channels) : A low intracellular concentration of
ATP leads to efflux of K+ ions thus limiting myogenic depolarization and control of
myogenic tone. Standen et al. (1989) first reported the role of KATPchannels in arterial
dilation in rats. The inhibition ofK ATPchannels induce vasoco nstriction and membrane
depolarization in various vascular smooth muscles (Nelson et al., 1990; Nakashima and
Vanhoutte, 1995, Quayle et al., 1997; Teramoto, 2006). Several endogenous agonists
such as calcitonin gene-related peptide (CGRP) and adenosine activate KATPleading to
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hyperpolarization and relaxation, a response that is mimicked by treatment with KATP
openers . In contras t, various neurotransmitters (noradrenaline, 5-hydroxy trypta mine (5-
HT), neuropeptid e Y and vasoco nstrictors angiotensin II, endothe lin- I) inhibit KATP
leading to depolarization and contraction (Quayle et al., 1997). Pathophysiological
involvement of KATPis reported in systemic arterial dilation durin g hypoxia, reactive
hyperaemia in coronary and cerebral circulation, and acidos is- and endotoxic shock-
induced vasodilation (Brayden, 2002, Teramoto, 2006; Ko et al., 2008) . Moreover , the
inhibition of KATPleads to impaired corona ry and cerebra l autoregulation (Nelson and
Quayle, 1995). The KATPare hetero-octameric complexes containing four pore -forming,
inwardly recti fying channel subunits (Kir6.1or Kir6z), together with four sulphonylurea
receptors (SU Rs), which are an ATP-binding cassette (ABC) family of proteins
(Terarnoto, 2006; Ko et al., 2008) . In vasc ular smoo th muscle cells, the KATPare
comp osed of Kir6 .X (Kir61or Kir6.2)/SUR2B (Standen and Quayle, 1998; Tera rnoto, 2006;
Ko et al. , 2008). Exogenously, the KATPin smoot h muscle are known to be inhibited by
glibenclamide and tolbut amid e (anti-diabetic sulphonylurea drugs) (Ne lson and Quayle,
1995; Quayle et al., 1997; Standen and Quayle, 1998; Tera moto, 2006 ; Ko et al., 2008) .
Various agents that open KATPare crornakalim, levcromakalim , nicorandil , pinacidil,
minoxidil , diazoxide, and BRL-55834. The vasodilation and hyperpolarization induced
by these agents can be blocked by glibenclamide (an antago nist of KATP channels)
(Quaylee tal., 1997).
Two-pore domain potassium channel (K2P) : The membr ane proteins with four trans-
membrane domain s (TMD) and two pores (P) domains that select ivity allow K+ ions
efflux are referred as two-pore domain potassium channels. This uniqu e feature is at the
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origin of their name, 2P domain K+ channels or K2Pchannels (Lotshaw, 2007). The K2P
channels are composed of four potential transmembr ane segments (M I-M4 ), the 2P
domains (P I and P2), short NH2-termin al and long COOH-terminal cytoplasmic parts,
and an extended extrace llular loop between MI and PI. The connectin g loops between M
domains are generally short , although the sequence connecting M I and M2 is typically
longest and include s the first pore domain (P I). The M I-M 2 extrace llular linker domain
usually contains one or more asparagines which may function in N-l inked glycosy lation
and one or more cystein es which may form disulfid e bridges between subunits (Lesage
and Lazdun ski, 2000 ). Isoform-specific amin o acids have also been ident ified within this
domain that contributes to import ant pharmacological cha racter istics (Enyedi and Cz irjak,
20 I0). The second pore domain (P2) is located between the M3 and M4 domains. The
proton ation of histidin e 98 (His98) in the first pore (P I) is partly responsible for
inhibition of the Tandem of P domains in Weak Inward rectifier K+ channel (TWIK)-
related acid sensitive K+chann els (TASK) (Duprat et al., 2007). The cytoso lic C-
termin al domain has also been shown to play several important roles in modul ation of
channel gating. Other than pore domains, these subunits do not share significant
sequence homolo gies with the 6TMSII P and 2TMSII P subunits (Lesage and Lazdunski,
2000; Lotshaw, 2007; Enyedi and Czirja k, 2010). However, based on gene sequence
similarities, K2Pchannels are divided into six subfamilies that includes Tandem of P
domains in Weak Inward rectifier K+channel (TWIK ), TWIK-Related K+ channel
(TREK) and TWIK-Related Arachidonic Acid stimulated K+ channel (TRAA K), TW IK-
related Acid Sensitive K+ channel (TAS K), TWIK-related Alkaline pH activated K+
channel (TAL K), Tandem-pore dom ain Halothane Inhib ited K+ channel (TH IK)
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(Lotshaw, 2007; Gurney and Manoury, 2009, Enyedi and Czirjak G, 2010). The latter
mentioned proteins are expressed in various tissues and extensively studied in the central
nervous system (Talley et al., 2001; Lesage, 2003; Lotshaw, 2007). The K2P channels
expressed in the systemic and pulmonary circulations are regulated by various chemical
and physiological stimuli such as pH, oxygen, phospholipid s, neurotransmitters, GPCRs
and volatile anaesthetics. Moreover, stretch regulates the function s of K2P channels under
a range of physiological and pathological situations (Lesage and Lazdunski 2000; Mathie
2007). This sensitivity to a wide range of physiological signals (polyunsaturated fatty-
acids, pH, 0 2) that are important in regulating blood flow makes them important
candidates as regulators of vascular tone, especially in small resistance vesse ls of the
systemic circulation, such as mesenteric and cerebral arteries (Blondeau et al., 2007;
Garry et al., 2007), and the pulmonary circulation (Gardener et al., 2004; Gurney et al.,
2003). The arachidonic acid sensitive K2P channels expressed in the cerebral artery, rat
mesenteric and femoral arteries are TREK- I, TREK-2 and THIK (Lesage and Lazdunski,
2000). The TRAAK was reported in mesenteric but not femoral artery (Gardener et al.,
2004; Gurney and Manoury , 2009). The carotid arteries and pulmonary arteries lack
TREK- I and TRAAK. The pulmonary artery contains TASK - I, TASK-2, TREK-2,
TWIK-2 and THIK I (Gardener et al., 2004; Blondeau et al., 2007; Gurney and Manoury,
2009). Functional and electrophysiological studies performed on mice deficient in
TREK- I suggest that it has a role in endothelial cells to regulate cerebral vascular tone
(Blondeau et al., 2007). The TASK- I and TASK-2 channels expressed in pulmonary
artery of various animals have shown to regulate arterial tone in response to various
physiological stimuli (pH, O2) . Treatment with acidic buffer (pH 6.5), Zn2+, or
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anandamide depolarize the resting membrane potential by blocking the background
channel, i.e. TASK (Maingret et al., 2001). The participation of TAS K in control of
vascular tone seems to be more important in pulmonary vasculature as compared to
systemic arte ries (Gardener et al., 2004).
1.3.2.3. Calcium channels
An increase in intracellular Ca2+ levels mediated by voltage-gated channels triggers a
range of cellular responses such as the regulation of Ca2+-dependent second messengers,
Ca2+ release from cytoplasmic stores, gene expression and smooth muscle contraction
(Xiong and Sperelakis, 1995). Based both on pharmacological and biophysical profiles,
voltage-dependent Ca2+ channels have been classified into T-, L-, N-, P/Q-, and R-types
(Bean, 1989; Pietrobon, 2005). Out of five different subtypes of voltage-dependent Ca2+
channels, L-type (long lasting/kinetically slow) and T-type (transient! kinetically fast)
have been described in various vascular smooth muscle cells (Sturek and Hermsmeyer,
1986; Bolton and Pacaud, 1992). The kinetics of activation or inactivation is slow for L-
type Ca2+compared to T-Ty pe channels with different operational voltage range. The L-
type Ca2+ channels operate at high threshold (activation voltage of -45 to -35 mY) with
single channel condu ctance of 18-26 pS; and T-type Ca2+ channels operate at low
threshold (activation voltage of -60 to -50 mY) with single channel conductance of8-12
pS (Xiong and Spere lakis, 1995; Cribbs, 2006). Whereas L-type channels function
primarily to regulate Ca2+ entry for contraction, it is generally accepted that T-type Ca2+
channels do not contribute significantly to arterial vasoco nstriction, with the possible
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exception of the renal microcirculation. The L-type channels are regulated by cyc lic
nucleotides and phosphorylation while T-types are not (Cr ibbs, 2006). Finally, L-type
Ca2+ channels are inhib ited by verapamil, dilti azem and nifedipine, and activated by Bay
K8644 (Ca2+channel agonist). The T-type channels are blocked by tetrameth rine, R (-)-
efonidipine and NN C 55-0396 (Jensen and Holstein-R athlou, 2009) .
1.3.2.4. Chloride Channels (CI}
The chloride channels are abundantly distribut ed in smoot h muscle memb ranes (Kitamura
and Yamaza ki; 200 1). Vascular smooth muscle cell mainly includes two types of Cl
currents, i.e. calcium dependent chloride currents and volume regulated curren ts
(Chipperfie ld and Harper 2000; Kitamu ra and Yamazaki ; 200 1). Age nts (such as
noradrenaline, caffe ine and the Ca2+ ionophore A-23 I87) that increase intracellu lar
concentration of ci+have been reported to activate cr currents in the smoot h muscle
cells (Byrne and Large, 1987a,b). This change in chloride conductance produ ces
membr ane depolarization , which leads to the opening of voltage dependent Ca2+ channe ls
thus leadin g to an influx of Ca2+ and hence contrac tion (Baron et al., 199 I ; Criddle et al.,
1997). A seco nd type of cr currents has been reported to be activated by mechanical
stress that occurs durin g vascular distention caused by high systolic pressure. The
mechanical stress induced elevations in cr conductance leads to the vasc ular con traction ,
thus reduc es the arteria l diameter (Nelson et al., 1997). Criddle el al. (1997) reported that
niflumi c acid selectively inhibited the agonist-induced contrac tion without altering the
high K'vevoked contraction in mesenteric artery of rat. In parallel , He and Tabrizchi
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(1997) demonstrated that niflumi c acid antagon izes the ur-adrenoceptor-induced
contractions in isolated perfused mesenteric blood vessels. In addition, cr channels play
a role in mainten ance of Emof vascular smooth muscle cells by altering the
transmembrane chloride concentration. This is affirmed by the use of var ious cr channel
agonists and antagonists (niflumic acid, indanyloxyacetic acid 94 and diphenylamine-2-
carboxylic acid) (Large and Wang, 1996; Criddle et al., 1997; Kitamura and Yamazaki;
200 1).
1.3.3. Endothelial cell layer (Endothelium)
Until the late 1900s, endothelial cells were considered a homogeneous population of cells
merely forming an inert barrier to separate the vascular space from the interstitium.
Ground-breaking investigations by different research groups recognized the fundamental
importance of endothelial cells in the regulation of vascular smooth muscle tone. Further,
recognizing the role of endothelium in coagulation stressed the fact that it's not a merely
passive barrier (Moncada et al . 1977; Furchgott and Zawadzki, 1980; Furchgott, 1983;
Palmer et al., 1987, 1988). The landmark report by Furchgott and Zawadzki (1980)
unravelled the obligatory role of endothelial cells in the acetylcholine-evoked relaxations
in isolated arteries of the rabbit. Since then, this pivotal observation has since been
extended to a wide variety of blood vesse ls from different species, including humans
(Feletou and Vanhoutte , 2009). Later in 1987, Ignarro et al. proposed that the endothelial
mediator involved in endothelium-dependent relaxation is nitric oxide (NO), which
stimulates soluble guanylate cyclase in vascular smooth muscle cells leading to increased
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levels of cyclic guanosine monophosphate (cyclic OMP), and thus relaxation. The latter
ground-breaking observatio n was further substantiated by reports publ ished by Palmer
and coworkers (1987, 1988). Evidently, there is a general agree ment in the scientific
community that NO is indeed a major endothelium-derived relaxing factor (EDRF). The
discovery of var ious nitric oxide synthase (NOS) inhibitors aided in exploring the
physiological role of NO in the vascular walls (Rees et al., 1989). These pharmacological
tools (NOS inhibitors) also made evident that NO is not a sole mediator of EDRF (Rees et
al., 1989). In certain blood-ve ssels, prostacyclin released from endothelial cells evoked
noticeable vasorelaxation by activatin g the production of cyclic adenosine
monopho sphate (cyclic AMP) (Moncada and Vane, 1979; Furchgott and Vanhoutte ,
1989). The endothelium dependent relaxation was observed in various blood vessels in
the presence of NOS and a prostacyclin inhibitor. These endothelium-dependent
relaxations were attributed to hyperpolarization of vascular smooth muscle triggered by
the endothelial cells, and led to the postulation of the existence of endothelium-derived
hyperpolarizing factor (EDHF) (Feletou and Vanhoutte, 1988; Nakashima et aI., 1993).
1.3.3.1. Nitric oxide (NO)
Nitric oxide generated by the vascular endothelium is a major regulator of vascular
homeostasis , and change s in its bioavailability are now known to playa role in the
development of a number of diseases (hypertension, atherosclerosis, stroke etc.)
(Vanhoutte et al., 2009). The impaired vascular function is common to the latter clinical
conditions (Vanhoutte et al., 2009). Palmer et al. (1987, 1988) reported the release of NO
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and enzymatic formation of NO in the vascular endothelium. NO is a by-product from
the convers ion of the sem i-esse ntial amino acid L-arginine to L-citrulline, a reaction that
is catalyzed by eNOS (Palmer et af ., 1988). NO is a free radical species that carries
unpaired electrons on its outer shell. It is highly reactive with a half life of 3-5 seconds
(Moncada et af., 1989). NO reacts with superox ide (0 2' ) and other reactive oxyge n
species to produc e a highly cytotox ic reactive nitrogen species know n as peroxynit rite. In
addition, NO exhibits low water solubility that aids the gaseo us molecule to diffuse
rapidl y across physiological membranes into the adjace nt smoot h muscle cells (Andrews
et af., 2002) .
The endothelial nitric oxide synthase (eNOS or NOS III) is one of three isoforms of the
enzyme that is mainly localized in caveolae in the memb rane of endothelial cells. The
other two isoform s are neuronal nitric oxide synthase (nNOS or NOS I) and inducible
nitric oxide synthase (iNO S or NOS II) (Moncada and Higgs, 2006). The eNOS is
constitutive ly active in the endothelial cells. An enzyme contains var ious domains; the C-
termin al of eNO S is referred as reductase domain that provides a bind ing site for
nicotinamid e adenine dinucleotide phosphate (NA DPH), flavin adenine dinucleotide
(FAD), and flavin adenine mononucleotide (FMN) (Palmer et af. , 1987; Moncada and
Higgs, 1995). The N-t ermin al provides an oxyge nation site (heme protein) for L-argi nine
and is know n as the oxygenation domain. This domain also has a site for a co-fac tor,
tetrahydrobi opterin (BH4) . The commissure where both reductase and oxyge nase
domains join is a bindin g site for calmodulin and acts as a switch to regulate the flow of
electrons between the two domains (Moncada and Higgs, 2006) .
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The generatio n of NO by agonists (bradykinin, substance P and acetylcholine) was
originally considered to be regulated by [Ca2+]i ions. This was confirmed by chelation of
extrace llular Ca2+or with the presence of an antagonist of calmod ulin that abolishes NO
production in response to these agonists (Luckhoff et al.. 1988; Busse and Mulsch 1990).
The mechanism of Ca2+dependent activation has been extensively studied and it is
recognized that the various agonists activate phospholipase C, leadin g to increases in
cytoplasmic Ca2+and diacyl glycerol. The increa ses in [Ca2+]icause displac ement of the
eNOS, thus allowin g calm odulin access to its bindin g site on the eNOS. The bindin g of
Ca2+/calmodulin to the domains connecting region of eNOS result s in an NADPH-
dependent flow of electrons from the reducta se region of one monomer of eNOS to the
heme iron in the oxygenase region of the other monomer initiating the synthes is of NO
(Moncada and Higgs, 2006). However, it is also now evident that eNOS could be
activa ted by certain stimuli without a sustained increase in [Ca2+];being necessary. For
example, shear stress, a stimulus generated by blood flowing on the endothelial cell
surface enhances the producti on of NO by two to fourfold over basal values that is
maintained as long as the stimulus is applied (Hoye r et al., 1998). Initially, the
generation of NO in response to shear stress due to the activa tion of eNOS was thought to
be Ca2+-independent. However further, investigation reveals that there is an initial
transient increase in [Ca2+]i when shear stress is applied (Hoye r et al., 1998). This was
also confirmed by inhibition of shear stress-induced activation of eNOS by chelation of
intracellul ar Ca2+. Thi s has led to the view that activation of eNO S by shear stress
actually requ ires Ca2+; and the enzyme could be phosphorylated at resting [Ca2+]i levels to
generate NO (Dimmel er et al., 1999). The mechanism by which shear stress genera tes
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NO involves the phosphatidylinositol 3-kinase (PI3K) pathway, leading to the activation
of serine kinase Akt- Iwhich phosphorylates eNOS on Serl 177 (Dimmeler et al., 1999;
Fulton et al., 1999). In endothelial cells, eNOS has also been reported to be activated via
O-protein-coupled receptors (Schini-Kerth and Vanhoutte, 1995).
In vascular smooth muscle cells, the main target for NO is the enzyme, soluble guanylyl
cyclase (sOC) , that catalyses the conversion of OTP into the second messenger molecule
(cyclic guanosine monophosphate; cGMP) that ultimat ely causes relaxation. The
activation of sOC arises when NO interacts with its heme moiety to form a complex that
ultimately induces conformational changes in the enzyme which exposes the catalytic site
to OTP (Hobbs, 1997). The cOMP induces relaxation by decreasing Ca2+flux by
inhibiting the flow through voltage-gated ci+channels (Lincoln, 1989). In addition,
cOMP also activates cOMP-dependent protein kinases (Schlossmann and Hofmann 2005)
protein kinase 0- 1(PKO I). Further, PKO I phosphorylates proteins in the sarcoplasmic
reticulum , including the Ca2+-activated K+channels (Archer, 1994), the IP3 receptor-
associated cOMP kinase substrate (Hirata et al., 1990) and phospholamban (Cornwe ll et
al., 1991). The phosphorylation of these proteins leads to the sequestration of Ca2+ in the
sarcoplasmic reticulum , reduction of cytosolic Ca2+and vascular relaxation.
Damage to the endothelium perturbs vascular homeostasis. The impairment in NO
production or bioavailability is an important risk factor for hypertension and other
cardiovascular diseases; and is referred to as endothelial dysfunction. The endothelial
dysfunction is measured as a decrease in endothelium-dependent vasodilation induced
either by appropriate agonists (Schachinger el al., 2000) or by shear stress due to flow
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(Neunteufl et al., 2000). This has been demonstrated in both animal and human
hypertensive populations (Vanhoutte et al., 2009). In an animal model, Ca2+dependent
NOS activity was reported comparable between aortas of hypertensive and normotensive
rats (Nava et al., 1996). However, NO production was normal in spontaneously
hypertensive rats, but 0 2- production was elevated and led to increased oxidation of NO,
resulting in a decreased vasodilatation response (Heitzer et al., 2000). The superoxide ion
could arise from a variety of sources, includin g NADPH oxidases and cyclo-oxyge nase
and these enzymes are reported to be up-regulated in hypertension (Vanhoutte et al.,
2009). Taken together, evidence seems to suggest that essential hypertension is
associated with reduced endothelium-dependent relaxation, where the functional role of
NO is regulated through its destruction or modification by another radical, namely
superox ide.
1.3.3.2. Endothelium dependent Hyperpolarizing factors (EDHF)
The EDHF is not a single factor that is synthesized in endothelial cells diffusing to
adjace nt vascular smooth muscle cells to elicit hyperpolarization. The EDHFs represent a
pool of various mediators that are released with EDRF from endothelial cells by various
endothelium-dependent vasodilators (Feletou and Vanhoutte, 2009) . Along with NO,
numerous other factors such as arachidonic metabolites (cyclo-oxyge nase derived
prostacyclin , PG!z; cytochrome P450 mono-oxygenase derived epoxyecosa trienoic acids,
EETs; lipoxygenase derived 12 -(S)- hydroxyeicosatetraenoic acid, HETE), gaseous
molecules (carbon monoxide, CO; hydrogen sulphide, H2S), reactive oxygen species
32
(hydrogen peroxide, H20 2) , vasoactive peptides (C-type natriuretic peptide, CNP;
vasoactive intestinal peptide, VIP; calcitonin gene-related peptide, CGRP and
adrenomedullin) and adenosine, mediate their effects by activating K+channels and/or
gap jun ctions causing hyperpolarization of underlying smooth muscle cells (Feletou and
Vanhoutte, 2009).
The EDHF-mediated responses are characterized as a non-NO/non-P Gh mediated
endothelium-dependent vasorelaxation response that is accompanied by hyperpolarization
of vascular smooth muscle. The EETs (I I, 12 EET ; 14, IS EET), generated in the
endothelial cell by cytochrom e P450, diffuse into adjacent smooth muscle cells and
activate BKc• channels causing hyperpolarization (Feletou and Vanhoutte, 2009 ;
Campbell and Fleming, 20I0). Inblood vessels, bradykinin, pulsatile stretch and shear
stress have been reported to release EETs that hyperpolarize underlying vascular smooth
muscle cells by activating large-conductance Ca2+-activated K+(BKc.) channels (Huang
et al., 2005; Weston et al., 2005). Alternatively, Earley et al. (2005) reported that EETs
activate vanilloid transient receptor potential channels type 4(TRPV4 ). The Ca2+ influx
through TRPV4 increases the frequency of unitary Ca2+release events (Ca2+sparks) via
ryanodine receptors located on the sarcoplasmic reticulum of cerebral artery smooth
muscle cells. Further, EET- induced Ca2+sparks activate nearby sarcolemmal BKc.
channels. Like EETs another arachidonic metabolite, lipoxygenase derived 12-S-HETE,
was reported to be released by endothelial cells of porcine coronary artery and rabbit
aorta and activate sarcolemmal BKc• channels, thus causing hyperpolarization of smooth
muscle cells (Pfister et al., 1987; Zink et al., 2001). The endothelium-dependent
relaxations evoked by lipoxygenase derivatives are restricted to few blood vessels
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(Feletou and Vanhoutte, 2009). Other mediators that recently joined the EDHF club are
CO, H2S and H20 2. Carbon monoxide is a by-produ ct derived from degradation of heme
by heme-oxygen ase. Like 12-S-HETE, CO vasodilator action is restrict ed to few blood
vessels. CO is a dif fusible gaseo us molecule that induces cGMP -mediated act ivation of
BKca and direct activat ion ofKATPand voltage -gated K+channels (Kv) in the smoot h
muscle cells (Wu and Wang, 2005). In contrast, CO is also recognized as a NOS
inhibit or via bindin g to prosthetic heme site of the latter enzyme and could contribut e to
endothelial dysfun ction (Baraga tti et al., 2007). Although, the H2S molecule has been
shown to hyperpol arize blood vesse ls, it is mostly expresse d in vascular smoo th muscle
cells and virtually absent in endothelial cells (Wang, 2002) . The last memb er of gaseo us
EDHFs is H20 2 which is deriv ed by the reaction of superoxide dismut ases with
superoxide ion. The H20 2 molecule acts as an important antiox idant defense in nearly all
cells exposed to oxygen. The H20 2 elicits endothelium-dependent relaxat ions by vario us
pathways such as by activation of cGMP and various K+channels (BKca, KATP, Kv and
KiT) (Ellis and Triggle, 2003; Shimokawa and Matob a, 2004) . However, in certain vessels
H20 2 mediated relaxation is not always assoc iated with hyperpolarization of smoo th
muscle cells (Chaytor et al., 2003) . Amongst the vasoac tive peptid es, C-type natriur etic
peptid e (CN P) has been investiga ted in mesenteric and caro tid arteries and various veins
(Ahluwalia and Hobb s, 2005; Feletou and Vanhoutte, 2009) . As with other EDHF
candidates, CNP evoked hyperpolarization is due to stimulation of cGMP that activates
the BKca channels (Wei et al., 1994). In addition, CNP has also been reported to activate
G-protein regulated inward-r ectifi er K+channels (GIRK) independent of stimulation of
cGMP (Villar el al., 2007).
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Common to all EDHF induced hyperpolarization is activation of the K+ channels presen t
on vasc ular smooth muscle cell s. This underscores the importance of K+ ions as front
runner in the race for the EDHF crow n. The contributi on of two calcium activated K+
channels that have been rigours ly investigated for EDHF are the intermediate and small
conduct ance Ca2+ activated K+channels (IKea, SKea). These channels are expressed in
the plasma membran e of vascular endothelial cells. The endothelium-dependent relaxant
agonists elevate the intracellul ar level of Ca2+and activate IKea and SKea channels that
further cause effl ux of K+ into the extracellular space . The accumulation ofK+ in the
extracellular space can provoke relaxation and/or hyperpolarization of vasc ular smooth
muscle cells by activating K, and/or the Na+/K+ATPase pump (Edwar d et a/., 1998).
Similar hyperpolarization was observed by raising the extrace llular K+ concentration (5-
15 mM) in various blood vessels (Hendrickx and Castee ls, 1974 ; Nelson and Quayle,
1995; Prior et al., 1998; Edward et a/., 1998). In most blood vessels, pharmacological
tools used to study these two channels are chary bdotoxin and TRAM-34 (for blocki ng
IKea); and apamin, scy llatox in and UCLl684 (for inhibiting SKea) (Ney lon et a/., 1999).
Follow ing activa tion of IKea and SKea channels, the efflux of K+ from intrace llular space
to extrace llular space in the endothelium in intact blood vesse ls supposedly occurs
through hetero-cellular hemi- channels known as myoendothelial gap jun ctions (MEGJ).
The MEGJ play an integra l role in the EDHF-mediated responses. Inhibition of these
junctions by gap jun ction inhibit ors (peptides, GAP-27; u-glycyrrhet inic acid derivatives;
carbenoxo lone and heptanol) attenuates the EDHF-mediated and endothelium-dependent
relaxant responses in various blood vesse ls (Yamamoto et al., 1999; Sandow and Hill ,
2000; Sand ow et a/., 2002; Dora et a/., 2003; Haddock et a/., 2006). The gap junctio ns
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are herni-channels (connexins) that aid electrical coupling between same cells (smooth
muscle cells-smooth muscle cells; endothelial cells-endothelial cells) referred to as homo-
cellular gap jun ctions; and between two different cells (smooth muscle cells-endothelial
cells) referred to as hetero-cellular gap junctions (Schmidt et al., 2008) . In blood vessels,
the gap junctions are made of connexins (Cx) 37, 40 and 43 (Haddock et al., 2006;
Schmidt et al., 2008). Sandow and Hill (2000) reported that the number ofMEGls
increase with the reduction in the size of the artery. In small arteries such as mesentery
artery, SKea co-localizes with Cx37, Cx40, and Cx43 and is adjace nt to endothelial cell
gap junctions, whereas IKea co-localize with Cx37 and Cx40 in myoendothelial gap
jun ctions (Sandow el al., 2006) . This co-localization of channels in MEGls aids in the
transmission of endothelial hyperpolarization to the underlying smooth muscle which
plays an important role in EDHF-mediated responses in many blood vesse ls. In addition,
with the aid of MEGls vascular electrical responses are conducted through a low-
resistance pathway provided by the endothelial cell layer (Dora, 20 I0). Various studies
with IKeal SKeal Cx knock-out mice have shown the importance of these components in
the cardiovasc ular system (Feletou and Vanhoutte, 2009). In genetically modified mice
(eNOS knockout mice), EDHF mediated responses play a compensatory role for the
absence of eNOS (Waldron et al., 1999; Brandes et al., 2000) . Deletion of IKeaand SKea
expression in the endothelial cells of transgenic mice showed elevated blood pressure
with reduced hyperpolarization noted in blood vessels in response to acetylcholine
(Taylor et al., 2003; Si et al., 2006). The endothelium-mediated relaxant responses have
been shown to attenuate in Cx 40 knockout mice. Further, theses connexins are suggested
to play a role in the development of hypertension and irregular arterio lar vasomotion (de
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Wit et al., 2003). Taken together, alteration of the EDHF pathway can also contribute to
these endothelial dysfuncti ons. The EDHF has been sugges ted to play a compensatory
role in the loss of NO bioava ilabil ity (Fe letou and Vanhoutte, 2009). An anomaly in the
function or express ion of various proteins expressed in vascular smoot h muscle and
endothelial cells could affect the dilator function of blood vessels that is critica l for
optimal tissue perfusion.
1.3.4. Signalling pathw ays involved in vascular contraction
The interaction of chemi cal compounds (agonists) with cell surface receptors results in
the activation of various intracellul ar signalling pathways and generation of numerous
second messengers. The second messengers target various intracellul ar targe ts to
generate vasc ular smoo th muscle responses.
The phosphophatidylinositol 4, 5, diph osphate (PIP2) is an important constituent of all
plasma memb ranes (Hirasawa and Nishizuka, 1985). Its phosphodiesteric cleavage to
inositol I, 4, 5 triphosphate (IP3) and I, 2, diacylglycerol (DAG) has been linked to
various agonists such as acetylcholine (Van Breemen et al., 1984), histamin e (Tsuru,
1984), angiotensin (Smith, 1986), noradrenaline (Bulbring and Tomita, 1987), serotonin
(Lapetina, 1987), thromboxane A2 (Lapetina, 1987), ATP (Nort h, 2002) , and vasopressi n
(Crooke et al., 1988). The phosphatidylinositol (PI) undergoes two-stage
phosphorylation in the inner plasma membr ane to form PIP2, which is the precursor for
receptor activation by external stimuli (Hirasawa and Nishizuka, 1985). Receptor
occupat ion stimulates G-protein regulated phospholipase C that hydrolyse PIP2 to
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produce IP3 and DAG (Hirasawa and Nishizuka, 1985). DAG is immediately
phosphorylated to phosphatidic acid (PA) by kinase in presence of ATP (Hirasawa and
Nishizuka, 1985). 1P3 is the intracellular mediator of Ca2+ release from the endoplasmic
Figure 1. A schematic summarizing signalling involved in vascular smooth muscle cell for the process of contraction and
relaxation . Adenylyl cyclase , (AC); adenosine 5-triphosphate, (ATP); ATP -sensitive potassium channel, (KATP) ; calcium,
[Ca2+]; intracellular concentration ofCa2+,([Ca2+]i); extracellular concentration ofCa2+, ([Ca2+]o); calmodulin, (CaM) ; calcium
ATPase enzyme , (CaATPase) ; 3·-5'-cyclic adenosine monophosphate, (cAMP) ; cyclic guanosine monophosphate, (cGMP) ;
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guanylyl cyclase, (GC); G-protein , (Gq) ; stimulatory G-protein (G, ); inositol 1,4,5-triphosphate, (IP3); 1,2 diacylglycerol ,
(DAG) ; myosin light chain kinase , (MLCK) ; myosin light chain phosphatase, (MLCP);phospholipase C, (PLC) ; nitric oxide ,
(NO) ; protein kinase A, (PKA) ; protein kinase G, (PKG) ; phosphophatidylinositol4, 5, diphosphate, (PIP2); receptor operated Ca
channel , (ROC) ; sarcoplasmic reticulum , (SR); receptor , (R); voltage operated Ca channel , (VOC); . Solid dark lines represent
pathways mediating contraction and solid light lines represent pathways mediating relaxation
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reticulum via IP3 receptors (Streb et al., 1984). Elevation of [Ca2+]i leads to binding of
Ca2+to calmodulin (CaM) to form Ca2+-CaM complex. This complex binds and activates
myosin light chain kinase (MLCK) (Dabrowska et al., 1978). Further, active kinase
complex (Ca2+-CaM-MLCK) phosphorylates the two 20-kDa light chain subunit of
myosin at serine'" and induces the cross-bridge cycling to generate force (Walsh, 1994).
The phosphorylated myosin is dephosphorylated by myosin light chain phosphatase
(MLCP), thus relaxing smooth muscle (Walsh, 1994). DAG is the membrane-associated
activator of protein kinase C (PKC) (Hirasawa and Nishizuka, 1985). PKC has been
shown to play an important role in sensitization of the smooth muscle leading to
contraction. This is referred to as sensitization of contractile elements that evoke
enhanced contraction at a given intracellular Ca2+concentration (Somlyo and Somlyo,
2003) . In addition, PKC targets nucleotide exchange factor on small molecular weight G-
protein (Rho subfamily) that further phosphorylates MLCP and results in sustained
contraction (Somlyo and Somlyo, 2003). PKC-induced sensitization could be also caused
by direct or indirect phosphorylation of MLCK by CaM kinase II and subsequently
decrease the affinity of the enzyme for Ca2+-CaM complex (Tansey et al., 1994; Somlyo
and Somlyo, 2003).
1.4. p-adrenoceptors in cardiovascular system
Catecholamines such as noradrenaline and adrenaline regulate physiological processes via
their interactions with a variety of membrane bound receptors. A landmark study by
Ahlquist (1948) divided these surface receptors into a- and p-adrenergic receptors on the
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basis of the relative potency of various agonists in generating cardiovascular responses.
Studies revea led that p-adrenoceptors can be sub-divided into PI, P2, PJ, atypical or P4
(Lands et al., 1967; Emorine et al., 1989; Kaumann et al ., 1997). It has also been
suggested that P4 might be the low affini ty state of the PI receptor (Kaumann et al., 200 1).
The p-adrenoceptors are expressed in the cardiovascular system and play an integral role
in the regulation of the same. PI- and p2-adrenoreceptors are expressed in the pump of the
circulatory system, i.e. the heart. Under normal physiologic conditions contractility
and/or heart rate is regulated by cardiac PI-adrenoceptors but it has been suggested that in
situations of stress , when large amounts of adrenaline is released from the adrenal
medulla, stimulation of cardiac P2-adrenoceptors could contribute to additional increases
in contractility and heart rate (Motomura et al., 1990; Brodde and Michel, 1999).
Moreover, the existence of'Bj-adrenoreceptors has been suggested to mediate negative
inotropic effects in myocardium (Gauthier et al., 2000), but their role remains unclear
(Heubach et al., 2000). The modifications in p-adrenoceptors seem to play an important
role in heart disease such as heart failure. The pronounced activation of the sympathetic
system in patients with heart failure seems to be inversely correlated with survival. The
cardiac p-adrenoceptors, in particular the PI subtype, are down-regulated in heart failure
(Brodde, 1993), and the remaining receptors are uncoupled from Gas,presumably via
increased activity ofG-protein receptor kinases (GRK2 and/or GRKS) (Ungerer et al.,
1993). In addition, an increase in Guiproteins in heart failure and congestive
cardiomyopathy direct its antagonizing effect on p-adrenoceptor-mediated cardiac
responses (Neumann et al., 1988; Bohm et al., 1990). Furthermore, the increased
sympathetic activity could aggravate the disease process via increased renin secretion and
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sodium retention, both of which could increase peripheral resistance and further increase
the work load for the heart. Increased renin secretion in part occurs by the activation of
p,-adrenoceptors in kidneys. The p,-adrenoceptors are present in high density on the
renin-containing ju xtaglomerul ar cells in the afferent arterioles (Johns, 198 I).
Stimulation of these receptors results in increased renin secretion rate causing no or
minimal changes in renal hemodynamics (Kopp et al., 1980). In addition, P2-
adrenoceptors have been found to localize in the collecting ducts, and activation of these
receptors may alter the transport properties of various tubular segments (DiBona and
Kopp, 1997). The increased production of renin leads to formation of angio tensin II via
the renin-angiotensin-aldosterone system (RAAS) . Further, angiotensin II causes blood
vesse ls to constrict, resulting in increased blood pressure, and it also stimulates the
secretion of the hormone aldosterone from the adrenal cortex . Aldosterone causes the
tubules of the kidneys to increase the reabsorption of sodium and hence water into the
blood. This increases the volume of fluid in the body, which also increases blood
pressure (Paul et al., 2006). Lastly, p-adrenoceptors are also expressed in the blood
transporting vesse ls of the circulatory system. The p-adrenoceptor-mediated vasodilation
plays an import ant physiological role in the regulation of vascular tone (Guirnaraes and
Moura, 200 I). Stimulation of peripheral p-adrenoceptors leads to relaxation of the
vascular smooth muscle and can regulate peripheral vascular resistance resultin g in the
distribut ion of blood to the different organs. So far, three subtypes of p-adrenoceptors
have been identifi ed in the mammalian blood vessels, i.e. PI,P2and P3(O' Donnell and
Wanstall, 1984; Shen et al., 1996; MacDonald et al., 1999; Chruscinski et al., 200 I;
Briones et al., 2005) . Stimulation ofp , and P2were suggeste d to play role in the
43
relaxation of both arteries and veins (Taira et al., 1977; Vatner et al., 1985). The
maximal relaxant response mediated via p-adrenoceptors varies amongst vascular bed and
species, for example: in some arteries such as cerebral and coronary arteries, the PI-
subtype plays an important role in relaxation (Edvinsson and Owman, 1974; O' Donnell
and Wanstall, 1985) whereas P2evoked relaxation responses is larger in veins (Molenaar
et al., 1988). In addition, the relaxant responses mainly depend on the level of tone of the
tissues (Begonha et al., 1995). In the 1990s, the existence of a subtype other than
classical PJ- and P2-adren oceptor involved in relaxation was reported in rat carotid,
mesentery and pulmonary arteries; rat aorta and canine pulmonary artery (Gray and
Marshall, 1992; Sooch and Marshall, 1995; Tamaoki et al., 1998; MacDonald et al.,
1999). With the discovery of p3-agonists (BRL-37344, CL-326243, CGP-12177 and ZD-
2079) and antagonists (SR-59230), p3-signalling has been studies in experimental models
(both in vivo and in vitro) . Although the P3-adrenoceptor has been shown to play a role in
regulatin g vascular tone, its role varies amongst species. Stimulation of P3-adrenoceptor
by BRL-37344 and CL-326243 in mice, rats and dogs led to reduction of blood pressure
and total periphe ral resistance (Tavernier et al., 1992; Shen et al., 1996; Rohrer et al.,
1999). In contrast, Shen et al. (1996) reported that P3-adrenoceptor agonists were not
able to evoke any cardiovascular effect in conscious primates like monkey and baboon.
Further, a propranolol (non-selective p-antagonist) resistant relaxant component in rat
aorta is not antagonized by selective inhibitors of PI, P2 and P3 receptors (atenolol, P,-
antagonist; ICI11855 , p2-antagonist; SR-59230) (Brawley et al., 2000). The later
suggests the presence of a fourth or atypical (P) subtype that participates in the relaxation
of blood vesse ls. Emerging literature on the atypical p-adrenoceptors suggests that it is a
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low affinity form of PI-stubtype that has a typical interaction with CGP-12l 77 (P3-
agonist) (Konkar et al., 2000). The physiological importance of p-adrenoceptor has been
elucidated in transgenic mice. In PI-knockout mice, high variability in blood pressure and
significantly low heart rate in response to isoprenaline were observed (Rohrer et al.,
1999). In p2-knockout mice, heart rate and blood pressure appear normal at rest but these
parameters were found elevated during exercise (Chruscinski et al., 1999). Inaddition,
the hypotensive response to isoprenaline is significantly attenuated in Prknockout mice
(Chrusc inski et al., 1999). Interestingly, in double knockout mice <PIand P2) the
upregulation of P3-adrenoceptor compensated for unaltered cardiovas cular responses.
This was shown by significantly enhanced cardiovasc ular responses (hypotension) to P3-
agonist CL-3 16243(Rohrer et al., 1999). Taken together, p-adrenoceptors play major
roles in blood flow distributi on to various organs (depending on the metabolic need) and
regulation of vascular tone.
1.4.I . p-adrenoceptor signaIling
The p-adrenoceptor is a GPCR and has u, P, y subunits as part of its infrastructur e. The
p-adrenoceptor is comprised of 4 I3 amino acid residues of approximately 46,500
Daltons. Like all GPCRs, the p-adrenoceptor has seven transmembrane-spanning n-
helices with three extraceIlular loops, with one being the amino terminus and three
intraceIlular loops with a carboxy-terminus (Emorine et al., 199 I). The overaIl amino
acid sequence identit y between the three receptors is about 50% and may reach up to 90%
in transmembrane regions that participate in catecholamine binding (MaruIlo et al., 1990).
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The resid ues involved in the bind ing of ligands to p-adrenoceptors are associa ted with the
seven transmemb rane regions, arranged in such a way that they form a pocket, and a part
of the extracellular hydrophilic loops joining the transmemb rane regions (Fraser, 1989).
Following bindin g of the ligand to the receptor, the conformational changes activate Gus
in vasc ular smooth muscle cells (Scheid et al., 1979) or G Ui in endothelial cells (Zheng et
al., 2005) that stimulates second messenger systems or activates ion channels. The
interacti on between p-adrenoceptors and the Gus protein depends on residu es from the
intra-cytoplasmic loops and the C-terminal region (O'Dowd et al., 1988). Furthermore ,
couplin g of Gus to adenylyl cycla se (AC) results in the activation of the enzyme and
catalyses the conversion of AT P to cAMP . The cAMP activates protein kinase A (PKA)
by bind ing to its regulat ory subunit, causing PKA to dissociate from the catalytic subunit,
thereby rendering it active. PKA is a serine/threonine protein kinase that targets a
numb er of intrace llular prot eins to produce vasc ular relaxation, involving a) PKA-
induced phosphor ylation of MLCK that result in decreasing the affinity of MLCK for
calmodulin thus relaxation of smoo th muscle cells (Somlyo and Somlyo 1994; Walsh
1994); b) activation of large-condu ctance, Caz+activated Kcachannels; c) activation of
K+channels resultin g in hyperpolarization and reduced Ca2+influ x (Chen and Rembold,
1992) and d) seques tration of Caz+ into internal stores (Tawa da et al., 1988). In addition,
the eNOS inhibitor NO-monomethyl-L- arginine (L-NMMA) attenuated the relaxation
respon se to pz-adrenoc eptors stimulation or to the cAMP analogue dibutyryl cAM P,
indicating that the NO -dependent component of the p-adrenoceptor relaxa tion response is
mediated largely through the elevation of cAMP. The levels of eNOS serine
phosphorylation were also found elevated on stimulation of p-adrenoce ptors in human
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umbil ical vein endothelial cells (HUVECs) (Yao et al., 2003). This was confirmed by
pre-treatment of HUVECs with the PKA inhibitor H89 that resulted in inhibition of P-
adrenoceptor-mediated serine phosphorylation of eNOS (Ferro et al., 2003) . Taken
together, it seems that p-adrenoceptor-mediated vasore laxation has both cAMP-dependent
and cAMP-independent components.
1.4.1.1. cAMP-independent pathways
Endothelial/N itric oxide/cGMP pa thway: The participation of endothelial cells/NO in P-
adrenoceptor-mediated vascular relaxation is controversial. On one hand, it has been
suggested that the removal of the endothelium or inhibitors of NOS was found to have no
influence on isoprenaline evoked relaxations in rat aorta (Moncada et al., 1991), canine
coronary arteries (White et al., 1986), rat carotid artery (Oriowo, 1994), or human internal
mammary artery (Molenaar et al., 1988); and on other hand, many authors showed that
removal of endothelium reduces the relaxations caused by p-adrenoceptor agonists in
several isolated vesse ls that include rat thoracic aorta (Brawley et al., 2000) , canine
coronary arteries (Rubanyi and Vanhoutte, 1985), mouse aorta (Akimoto et al., 2002) and
rat pulmonary artery (Bieger et al., 2006). Surprisingly, two different investigators
Moncada et al. (1991) and Brawley et al. (2000) showed opposite results in the same
tissue (rat thoracic aorta). It is plausible that different endothelial p-adrenoceptor (P3)
subtype mediate isoprenaline-evoked hyperpolarisation in rat thorac ic aorta. This
hypothesis was investigated by Trochu et al. (1999) and the evidence sugges ted that P3-
adrenoceptors are mainly located on endothelial cells, and act in conjunction with PI-and
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P2-adrenoceptors to mediate relaxation through activation of an NOS pathway and a
subsequent increase in cGMP levels. It was also found that P2-adrenoceptor-mediated
eNOS activation occurs independently of Ca2+and might be mediat ed via the
phosphoinosit ide 3-kinase /Ak t (ser ine/threonine protein kinase) pathway. This was
confirmed in rat thoracic aorta by treating the tissue with wortmannin (inhibitor of
phosphoinosit ide 3-kinases) and an Akt inhibitor resultin g in the inhibiti on of P-
adrenoceptor mediated eNOS activa tion (Ferro et al., 2004). Taken together, the role of
the endothelium in p-adrenoceptor mediated vasodilation is still unclear.
Role ofK channels in fJ-adrenoceplors signalling: The stimulation of p-adrenoceptors is
also associated with hyperpolarization of smooth muscle cells (Prehn et al., 1983;
Nakashim a and Vanhoutte , 1995; Ming et al., 1997; Fujii et al., 1999; Goto et al., 200 1;
Si eger et al., 2006; Garland et al., 20 11). This change in memb rane potential has been
linked to the opening of K+channels that vary amongst the vascular beds and spec ies.
For example, Nakashima and Vanhoutte (1995) demonstrated that stimulation of P-
adrenoceptors in canine saphenous vein involves the opening of KATI' channe ls and
venodilation. Similarl y, the activation of p-adrenoceptors in rat mesenteric arter ies has
been found to result in the opening of KATI' channels leadin g to the hyperpolarization of
vascular muscle (Fujii et al., 1999; Goto et a!., 200 I; Garland et al., 20 II ). Moreover,
Ming and colleag ues (1997) reported that in conscious dogs, p2-adrenoce ptor-mediated
dilation of resistance coro nary arteries involved the opening of KATI' channe ls as well as
the generation of NO. Si eger et al. (2006) demonstrated that isopre naline induced
hyperpolarization in the rat main pulmonary artery was assoc iated with the opening of
two-pore acid sensitive K+ channels (TAS K), but not the KATp channels. The activat ion
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of TASK following stimulation of'[l-adrenoceptors did not appear to be media ted via
cAMP/PKA activation (Bieger et al., 2006).
The p-adrenoceptor-activa ted AC/cAMP/PKA phosphorylates serine/threon ine residue on
[l-adrenergic receptor kinase (PARK) that further phosphorylates serine/threonine
residues on the p-adrenoceptor, thus facilitating bindin g of p-arres tins to the receptor
(Pitcher et al., 1992; Pippig et al., 1993). Binding of arrestin to the cytoplasmic loop of
the receptor occlude s the binding site for the heterotrim eric G-protein (Gas) thus
preventin g its activation (desensitization). Alternatively, arrestins cause the
internalization of the receptor via c1athrin coated pits and subsequent transport to an
internal compartment, called an endosome. Subsequently, the receptor could be either
targeted to degradation compartments (Iysosomes) or recycled back to the plasma
membrane where it can signal again (Lefkowitz and Shenoy, 2005) . The binding of
arrestin prevents the activation of p-adrenoceptor by agonists . In conclusion, pARK acts
as a negative feedback enzyme which will prevent over-stimulation of the p-adrenoceptor.
The p-adrenoceptor-mediated responses follow cAMP-dependent and independent
pathways. Interestingly, involvement of K+channels in p-adrenoceptor signalling varies
vastly with vascular tissues. What this diversity in p-adrenoceptor signalling signifies is
still unclear. Definitely much remains to be learnt about the mechanisms of p-
adrenoceptor signallin g in various tissues.
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1.5. High sa lt diet and cardiovascular diseases
Dietary salt is composed of sodium (Na+) and chloride (Cl) ions. The sodium ions are
the most abundant ions in extracellular fluid and they play a pivotal role in fluid and
electrolyte balance and in generation and conduction of membrane potentials in neurons
and muscle fibres (Tortora and Grabowski, 2010). Evidently, the daily increase of Na"
intake in most countries worldwide is largely due to excess dietary salt. This elevated
consumption of dietary salt cause a rise in blood pressure (hypertension) that further lead
to increases in cardiovasc ular (strokes, heart attacks and heart diseases) and renal diseases
(Intersalt study, 1988; Meneton et al., 2005; He and MacGregor, 2010) . Hypertension
has been reported as the biggest cause of death and the second biggest cause of disabi lity
after malnutrition in children worldwide (Lopez et al., 200 1). Consequences of high
blood pressure are mainly due to its effects on the cardiovasc ular system that cause a high
mortality rate worldwide. In the company of other factors such as high cholesterol and
smoking, hypertension accounts for over 80% of cardiovasc ular diseases (Emberson et
al., 2003). Howeve r, high blood pressure is the single most important cause, respons ible
for 62% of strokes and 49% of coronary heart disease (World Health Report, 2002). Over
the years, assiduous work of many researchers across the globe on salt-induced
hypertension and cardiovasc ular diseases has brought out the concept that in addit ion to
raising blood pressure dietary salt has direct harmful effects . Some of these
cardiovascular effects occur independently of pressure change (He and MacGregor,
20 I0). Tobian (1991) was the first to show that in various forms of experimental
hypertension in the rat, a high salt intake induces structural alterations in cerebra l and
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renal vessels independent of the change in blood pressure (Tobian and Hanlon, 1990;
Tobian, 1991).
1.5.1. Evidence linking high salt diet with cardiovascular diseases
A higher number of deaths due to stroke were reported from Japan (in the late 1950s) and
interestingly, these incidences had a regional distributi on that paralleled high salt
consumption as part of the diet (Sasaki, 1964). The salt intake in northern Japan on
average was 27 g/day, and 70% of the population (age of 50-60 years) had a high blood
pressure (systolic and/or diastolic over 150/90 mmHg) result ing in the highest prevalence
of cerebral haemorrhage (Sasaki, 1964). However, the southern region had a much lower
prevalence of cerebral haemorrhage due to lower salt intake, an average of 14 g/day ; only
10% of the population (same age range) had high blood pressure. A reduction in dietary
salt intake in these populations lowers arterial blood pressure and leads to an 80%
reduction in mortality due to stroke. Thus overall the reduction in salt intake appea red to
be associated with a large decrease in deaths from stroke (Sasaki, 1979; Intersalt study,
1988). Further, a large international study on salt and blood pressure (INTERSALT) was
conducted using a standardized method for monitoring blood pressure and 24-h urinary
sodium. Fifty-two communitie s with a wide range of salt intake from 0.5 to 25 g/day
were enrolled . However, the majority of recruited communities had salt intake of 6 and 12
g/day and only four had a low salt intake (3 g/day or less). In the latter study, it was
demonstrated that a significant positive relationship between salt intake, 24 hour urinary
sodium and blood pressures exists. There was also a highly significant positive
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relationship between salt intake and the increase in blood pressure with age. It was
estimated that an increase of 6 g/day salt intake over 30 years would lead to an increase in
systolic BP by 9 mmHg (Intersalt study, 1988). A commendable joi nt effort by the food
industry and Government of Finland in order to reduce salt in food products and to raise
the genera l awareness among consumers of the harmful effects of high salt consumption
on health has led to reduction of salt intake by one-third (Karppanen and Mervaa la,
2006). This results in a decrease of approximately 10 mmHg in both systolic and
diastolic blood pressures. Moreover, a pronounced reduction of 75-80% in mortality
associated with stroke and coronary heart diseases and an increase of 5-6 years in life
expectancy were also recorded (Laatikainen et al., 2006). The two large randomized
trials, the Trial of Hypertension Prevention (TOHP) I and II have demonstrated the long-
term effects of salt reduction on cardiovascular diseases (Cook et al., 2007). More than
3000 individuals with an average baseline blood pressure of 127/85 mmHg participated in
the studies and were randomized to a reduced-salt group (for 18 months in TOHP I and
36-48 months in TOHP II) or to a control group. The individuals in the intervention
group were advised to reduce their salt intake (average of 10 g/day) by 25-30%. These
reduct ions in salt intake resulted in a fall in blood pressure of 1.7/0.9mmH g at 18 months
(TOHP I) and 1.2/0.7mmH g at 36 months (TOHP II). The dietary advice was stopped
after the compl etion of the initial studies. The participants were followed for subsequent
development of cardiovascular diseases up to 15 years after the end of TH0 P I and 10
years after the end of THOP II. The intervention group with reduced-salt intake had a
25% lower incidence of cardiovascular events (Cook et al., 2007). Furthermore,
epidemiological studies in humans have shown that a high salt diet may have a direct
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effect in causing stroke, independent of, and additive to its effect on blood pressure.
Ferrara et al. (1984) reported that the increase in left ventricular mass assoc iated with
essential hypertension can be reduced by lowering the intake of salt. The Trea tment of
Mild Hypertension Study Research Group showed a significant correlation between the
reduction in salt intake and left ventricular mass. In another study group lowering salt
intake was also the only factor which was significantly correlated with a reduction in left
ventricular mass (Liebson et al., 1995). Lastly, consumption of low salt diet has been
shown to improve distensibility of central aorta and large peripheral arteries in
normotensive and elderly hypertensive (stage I) patients (Avolio et al., 1986; Gates et al.,
2004). This should have beneficial effects on the cardiovasc ular system.
1.5.2. Evidence from animal studies
The influence of a high salt diet on the cardiovascular system has been widely studied in
animal models. Numerou s studies in rats, mice, dogs, chickens, rabbits, baboons, pigs
and chimpanzees have all shown that high salt intake plays a role in regulating blood
pressure (Penner et al., 2007; Elliott et al., 2007). Denton et al. (1995) conducted a study
in chimpanzees (98.8% genetic homology with man) and demonstrated that a gradual
increase of salt intake from 0.5g/day to l Og/day over a period of20 months, results in
progressive elevation in blood pressure. After stopping the salt supplementation, the
blood pressure declin ed to that of control group over a period of 3-6 months. A study
conducted in pigs in which one group was fed a diet containing either 0.5% salt or 3% salt
for 8 months after weaning with free access to pure water. The average diastolic and
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systolic blood pressures became progressively elevated from the second to the eighth
month in the group of pigs with the high salt intake (Corbett et al., 1979). Among all the
mammalians, by far the most extensive investigations on the effect of high salt diet and
the underlying mechanisms have been conducted in rats. A number of studies reported
that Dahl salt sensitive and Spontaneous-Hypertensive rats when fed a high salt diet (4 -
8% NaC l) for 4-10 weeks develop hypertension and cause pressure induced adaptive
vascular hypertroph y (Folkow et al., 1971; Hampton et al., 1989; Simon et al., 2003) ,
ventricular hypert rophy (Kihara et al.,1985), hypertrophied kidneys with glomerular and
interstitial fibrosis (Blizard et al., 1991; Vaskonen et al., 1997), stroke (Tobian and
Hanlon , 1990; MacLeod et al., 1997), and cardiac failure (Frolich, 1999). The
normotensive (Dahl salt-resistant, Wistar-Kyoto) rats fed a high salt diet (2 - 8% NaCl)
maintains a normal blood pressure but other effect of excess Na+on the cardiovascular
system were observed such as increased left ventricular mass (Frolich, 1993), vascular
hypertroph y (Tobian and Hanlon , 1990; Tobian, 199 I), increased weight and size of
kidney (McCo rmick et al., 1989), stroke (Tobian and Hanlon, 1990) and cardiac failure
(Frolich, 1999). Thus, these observations suggested a link between high consumption of
dietary Na+and cardiovascular diseases by both blood pressure-dependent and blood
pressure-independent mechanisms.
The underlying mechanisms that result in salt induced vascular dysfunction have been
widely investigated. Numerous studies in rats and mice have suggested that salt-induced
vascular dysfunction may be linked to a defective L-arginine/eNOS / NO pathway. Chen
and Sanders (1991) demonstrated that the formation of NO plays an integral role in
resting arteriolar tone in Dahl salt-resistant and Sprague-Dawley rats. The NG_
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monometh yl-L-arginin e (L-NMMA; eNOS inhibitor) increased blood pressure by
abolishing endothe lium-de rived vaso dilation. It has also been reporte d that basa l cyclic
GM P levels were sig nifica ntly higher (7.8-fo ld) in blood vesse ls of normotensive rats
compared to hypertensive rats (Biege r et al., 2004). These result s sugge st that during salt
loadin g, salt-res istant rats are able to increase NO production , prevent ing the enhanced
blood pressure response. In contr ast, salt-sensitive rats showe d a defect in their ability to
increase NO production in response to high salt intake. It is plausibl e to state that Dahl
salt-se nsitive rats exhibit a marked down- regulation of vasc ular expressio n of eNOS. A
high salt diet co uld indu ce produ ction of superoxi de ions which reduce the
"bioavailability" of NO in the cardiovasc ular system. Furthermo re, blood vesse ls from
hypertensive anima ls have been reported to show more sens itivity to vasoco nstrictor
age nts such as noradr enalin e, sero tonin, ouabain, Bay K8644 (L-type calcium channel
ago nist), phorb ol ester (a prot ein kinase C activator), and endo the lin (Bohr and Webb ,
1988; Domin iczak and Bohr , 1989; Storm et al., 1990). The res ting Emrecorded from
vasc ular smoo th cell s ofrats fed a high salt diet varies from vesse l to vessel. Abe l et at.
(1981 ) record ed restin g memb rane potenti al of similar magnitud e in cauda l arter ies from
Dahl salt-sens itive (-50.2 ± 1.1mY ) and Dahl sa lt-res istan t (-5 1.4 ± 0.9 mY) rats fed a
high salt diet (8% NaC l). Similarly, Parai and Ta brizc hi (2005) reported that the resti ng
Emof smoo th muscle cells of mesentery arteries of Dahl sa lt-resis tant (-68 .0 ± 4.2 mY)
and Dahl salt-se ns itive (-67.2 ± 4.8 mY) rats fed a high sa lt diet (4% NaCl) were not
di fferent. In contra st, Fujii et at. (1997) reported di fferent Emin superior mesenteric
arter ies from Dahl sa lt-se ns itive (-4 1.4 ± 0.5 mV) rats that were significa ntly depolarized
compared to Dahl salt-res istant (-47.0 ± 0.7 mY) rats. A simi lar observ ation was made by
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Wellm an et al. (200 1) in cerebral arteries form Dahl salt-sensitive and Dahl salt-resis tant
rats. The resting Emof tail artery of spontaneously hyperten sive rats (-56. 1 ± 1.1 mV)
was significantly depolarized compared to their aged matched norm otensive controls, the
Wistar-Kyotos (-63. 7 ± 1.5 mY) (Cheung, 1984). Interestingly, Bieger et al. (2004) noted
hyperpolarization of resting EIII in smoo th muscle cells from pulm onary artery of Dahl
salt-sensitive comp ared to Dahl salt-resistant rats fed a high salt diet (4% NaCl). This
lack of consistency betwe en measured Emcould be attributed to the regional difference
among the blood vesse ls. Collectively, evidence sugges ts that the consumption of high
salt could lead to an altered EIII of smoo th muscle cell s and changes in signal transduction
within the vascular system that further affects the functional responses of blood vesse ls to
var ious physiologic al mediat ors.
1.6. Objectives of the study
Since Furchgott and Zawadski (1980) first reported that acetylcholine-media ted
relaxation of vasc ular smoo th muscle requires the presence of an intact endothelium, the
role of the endothe lium in the cardiovasc ular system has been extensive ly studied in
normal and disease states . Endothelium dysfunction has been found a common factor in
the gamut of cardiovasc ular diseases (Vanhoutte et al., 2009) . The p-adrenoceptor -
mediated vasorelax ation has long been considered as a cAM P dependent phenomenon
that take place in the vas cular smooth muscle cells (Scheid et al., 1979). The origina l
observat ion for the invo lvement of endothelial cells in p-adrenoceptor-mediated
vasorelaxa tion was made by Rubanyi and Vanhoutte (1985), who demonstrated that the
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remova l of the endothelium reduced the relaxation of canine coronary arteries caused by
p-adrenoceptor agonists. Since then various researchers have invest igated the role of
endothelium in different vascular tissues but its role still remains unclear. For example;
isoprenaline-induced relaxation in canine coronary arteries (White et al., 1986), human
internal mammary artery (Molenaar et al., 1988) or rat carotid artery (Oriowo, 1994),
were found to be endothelium-independent. Other reports demonstrated that remova l of
endothelium reduces the relaxations caused by p-adrenoceptor agonist in canine coronary
arteries (Rubanyi and Vanhoutt e 1985), mouse aorta (Akimoto et al. 2002) and rat
pulmonary artery (Bieger et al., 2006). Interestingly, two different researchers published
contradictory report s in the same tissue i.e. rat aorta, one group showed that p-
adrenoceptor-mediated relaxations were endothelium-independent (Moncada et al., 1991)
and the other reported that this was the case (Brawley et al.,2000). This variance in the
latter observations could be due to differences in experimental design i.e. different level
of tone placed on tissues. In addition, the impact of the presence of endothelium in p-
adrenoceptor-mediated electrical responses has remained unresolved.
Hypertension has been linked with reduced endothelium dependent relaxations in isolated
arteries from different animals (Lee and Triggle, 1986; Lee, 1987; Luscher et al., 1987).
However , consumption of high salt diet has been shown to increase the formation of NO
in Sprague-Daw ley rat fed a high salt diet (4% NaCl). This was demonstrated by
enhanced excretion of NO metabolites (Tolins and Shultz, 1994). In parallel, Bieger et al.
(2004) sugges ted that blood pressure of Dahl-salt resistant rats fed a high salt diet (4%
Naf. l) remained unchanged due to elevation of the vascular cGMP levels.
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Dietary salt intake has been shown to influence p-adrenoceptor-mediated vascular
response . High salt intake has been suggeste d to impair p-adrenocep tor-mediated
response (Feldman, 1990a). The reduction of salt intake results in normalized P-
adrenoceptor-mediated venodilation in borderline hypertensive patients or elderly
normotensive individuals (Feldman, I990a; Feldman, 1992). In animal studies, high salt
intake has variable effects on normalized p-adrenoceptor-mediated responses. The
isoprenaline-mediated vascular dilation was found to be significantly attenuated in aortic
rings from Dahl salt-sensitive rats fed a high salt diet (Soltis and Katovich , 1991). In
contrast, in low pressure segment of the circulatory system (i.e. pulmon ary artery), P-
adrenoceptor-mediated relaxant responses of Dahl salt-sensitive hypertensive rats were
not affected by consumpti on ofa high salt diet (Ford et al., 20 11). Furtherm ore, the
noradrenaline-medi ated vasodilation was attenuated in six and twelve weeks old
spontaneous hypertensive rats (Arribas et al., 1994). Altered p-adrenoceptor-induced
hyperpolarization has been reported in vascular tissues of hypertensive rats (Stekiel et al.,
1993; Goto et al., 200 1). Taken together, the evidence suggests that elevation in blood
pressure might interfere with p-adrenoceptor-mediated relaxation responses.
The consumpti on of a high salt diet has also been shown to modestly elevate systemic
blood pressure in Sprague-Dawle y rats which are considered to be normotensive (Sofola
et al., 2002) . Bieger et al.(2004) reported that blood pressure of Dahl-salt sensitive rats
following consumption of high salt diet (4% NaCl) for the period of7 weeks was
significantly elevated without inducing any change in mean pulmonar y pressures. The
absence of an elevated mean pulmonary pressure in the circulation may allow for the p-
adrenoceptor-mediated funct ional and electrical response to remain intact in a state of
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systemic hypertension. Considering the above evidence, we studied p-adrenoceptor-
mediated responses in the low pressure system i.e. pulmonary artery of Sprague-Dawley
rats. In addition, consumption of high salt also been found to elevate plasma sodium by I
to 3 mmol/L in patients with essential hypertension and in the spontaneously hypertensive
rat (SHR). The increase in sodium concentration greater than 2 mmol/L has been shown
to induce changes in vascular response independent of an increase in blood pressure (de
Wardener et al., 2004).
In order to study the effect of high salt diet on p-adrenoceptors, we first need to have an
understandin g of the p-adrenoceptor-mediated response independent of changes in blood
pressure. Earlier evidence from this laboratory supported the view that isoprenaline
induces hyperpolarization of pulmonary artery (Bieger at al., 2006). This
hyperpolarization was sensitive to inhibition by acidification of buffer and seems to be
due to the opening of the two-pore domain potassium channel (TAS K) (Bieger et al.,
2006). Studies from this and another laboratory suggested that isoprenaline-induced
relaxant responses in rat pulmonary artery were also in part endothelium dependent
(Priest et al., 1997; Bieger at al., 2006).
Therefore, the two main objectives of the present study were to:
A) Investigate the role of endothelium in p-adrenoceptor-mediated electrical
responses in the rat pulmonary artery.
B) Examine the effect of high salt diet on isoprenaline-induced electrica l and
mechanical responses in the rat pulmonary artery.
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1.7. Hypotheses
It is possible that a high salt diet alters p-adrenoceptor-mediated signalling independent of
changes in systemic blood pressure. In the present project a number of hypotheses were
tested in relation to p-adrenoceptor signalling in isolated blood vesse ls (main pulmonary
artery) from the low-pressure segment of the circulatory system. The first hypothesis
being that endothelium played an integral role in p-adrenoceptor-m ediated vascular
response i.e. electrical and mechanical. The second hypothesis being that consumptio n of
a high salt diet would alter p-adrenoc eptor-medi ated signalling in the blood vessel
independent of a change in intravascular pressure .
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2.0. METHODS
2.1. Study I. Role of endothelium in vascular p-adrenoceptor signalling
2. 1.1. Preparation of animal s
Six- seve n weeks old male Sprag ue-Daw ley rats (270 - 330 g) were housed (two per
cage) with 12h light/dark cycles and give n access to normal food (La bDie t 5POOProLab,
PMI Nutriti on Intern ational, Brentw ood, MO , U.S.A) and tap water ad libitum.
2.1.2. T issue iso lation
Each Sprag ue-Daw ley rat was anaest hetize d with halothane (5% in 100% oxygen) and
exsanguinated . The chest was cut open to access the thoracic cavity to remove cardio-
pulmonary organs. Lungs and pulmonary vascu lature along with the heart were
transferred into a dissecting dish con taini ng physiological buffer with the followin g
compositio n (in mM): NaC I, 130; KCI, 4.0 ; glucose , II ; MgCh, 1.2; CaCh, 2.5; KH2P0 4,
1.2; Na HCO J, 12.5; EDTA , 0.1. The pH of the buffer following saturat ion with a 95% 0 2:
5% CO2 gas mixture was 7.4 at 36 ± 1 °C. The main left and right pulm onary arte ries
were isolated , dissected free of conn ecti ve tissue and separa ted from the pulm onary trun k.
The endo the lium was removed in some blood vessel s by gen tle rubbin g with a string
made of cotto n wool.
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2.1.3. Experimental protocol
2.1.3.1. Mechanica l force measurements
Ring preparations from the right and left main pulmonary arte ries (-2 mm in length) were
mounted in 20 ml orga n baths at 36 - 37°C under a force of9 .8 mN and gassed
continuously with a mixture of95% 0 2: 5% C02 for mechanical studies . The tissues
were equilibrated for 60 min (washed twice at 30 min with physiological buffer), and
isometric tension was measured using force displ acement transducers (Model FT03 ,
Grass Instrum ents Co., MA, U.S.A.) connected to a polygraph (Mode l 7PCPB , Grass
Instruments Co., MA, U.S.A.) . Tissues were initially contrac ted with a single
concentration of phenylephrin e (1.0 I-lM), and the integrity of endothelial ce lls was
ascertained by the addition of methacholine (1.0 I-lM). Tiss ues were then washed with
physiological buffer and left for an additional 60 min (was hed once at 30 min with
physiological buffer) before they were contracted with phenylephr ine (0.3 - 1.0 I-lM)and
a contro l cumulative concent ration-response curve to isoprenaline (1.0 nM - 3.0 I-lM) was
constructed (Bieger et al., 2006). Following a wash with regular physiological buffer
and/or acidic buffer (pH 6.4; TASK- I antagonist) each tissue was incubated 20 min with
one of the follo wing: vehicle (twice-distilled water, 200 I-lL), BaCh (100 I-lM; K,
inhibitor) , ouabain (100 ~lM ; Na+/K+ATPase inhibit or), tetraethylamm onium (TEA, 3.0
mM; voltage gated K+ channel blocker) or combination of these interventi ons i.e. buffer
pH 6.4 plus BaCh (100 I-lM), buffer pH 6.4 plus ouabain (100 I-lM), pH 6.4 plus TEA (3.0
mM), BaCh (100 I-lM) plus ouabain (100 I-lM), buffer pH 6.4 plus BaCh (100 I-lM) plus
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ouabain (100 11M), BaCh (100 11M) plus TEA (3.0 mM), buffer pH 6.4 plus BaCh (100
11M) plus TEA (3.0 mM), BaCh (100 11M) plus ouabain (100 11M) plus TEA (3.0 mM),
pH 6.4 plus BaCh (100 11M) plus ouabain (100 11M) plus TEA (3.0 mM). Subsequently,
tissues were contracted with phenylephrine (0.3 - 1.0 11M) and a second cumulative
concentration-response curve to isoprenaline was constructed (1.0 nM - 30.0 11M).
Parallel experiments were carried out in denuded blood vessels.
2.1.3.2. Membrane potential measurements
Pulmonary artery rings were held under a tension of9.8 mN in a 5 ml sylgard lined tissue
chamber perfused with physiological salt solution pregassed with a mixture of95 % O2:
5% CO2 delivered at a rate of 3 - 4 ml per min and warmed to 34 - 35°C. Blood vessels
were allowed to equilibrate for 60 min, and the Emwas recorded with borosilicate
capillary microelectrodes filled with KCl (3.0 M) with a tip resistance of 10 - 20 MD.
The Ag/AgC I reference half-cell containing KCI (3.0 M) was connected to the bath via an
agar salt bridge containing 150 mM NaC!. Impalements were made by means of a
Narishige x-y-z micropositioner, typically from the intimal side at depths >50 11mbelow
the surface. Criteria for impalement and measurement of smooth muscle cell Emwere an
abrupt drop in voltage upon penetration of the cell membrane, a stable Emfor at least I
min, and a sharp return of the Emto zero upon withdrawal of the electrode from the cell
(Biegere l al.,2 006).
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Voltage signa ls were recorded by means ofAxoclamp-2A (Axo n Instrum ents Inc., CA,
USA), the output of which was fed into a Digi-Data 1200 Series Interface (Axon
Instrum ents Inc.). Data was acquired and displayed on AxoSco pe (Version 1.1) and
stored on a micro comput er. The Emfrom 3 - 6 cells was initia lly recorded prior to
exposure of the blood vesse ls to drugs. Subsequently, tissues were exposed to solutions
containin g isoprenaline (1.0 ~M) for 5 - 10 min, and the EIII of the cells was sampled. In
cases wher e inhibitors were used , followin g exposure to isoprenaline, tissues were
perfused with buffer cont ainin g no drugs for 10 - 15 min and then exposed to buffer
containing either buffer pH 6.4, BaCh (100 ~M), ouab ain (I 00 ~M), TEA (3.0 mM) and
combined interventi ons i.e. buffer pH 6.4 plus BaCh (I 00 ~M) , buffer pH 6.4 plus
ouabain (100 ~M) , pH 6.4 plus TEA (3.0 mM), BaClz (100 ~M) plus ouabain (100 ~M) ,
buffer pH 6.4 plus BaCh (I 00 ~M) plus ouabain (I 00 ~M) , BaCh ( I00 ~M) plus TEA
(3.0 mM), buffer pH 6.4 plus BaCh (100 ~M) plus TEA (3.0 mM), BaCh (100 ~M) plus
ouabain (100 ~M) plus TEA (3.0 mM), pH 6.4 plus BaCh (100 ~M) plus ouaba in (100
~M) plus TEA (3.0 mM ) . EIII recordin gs were carried out by sampling 3 - 4 cells
individually in each tissue ove r a period of at least 30 min afte r the addition of drugs or a
change in buffer (pH 6.4) before and during continuous perfusion with isoprenaline (1.0
~M) . Parallel experim ents were carried out in denud ed tissues. The integrity of the
endothelial cell was assessed with methacholin e as outlin ed in our mechanical force
investigation in a portion of the denuded blood vesse l. Inclusion of phenylephrine (1.0
~M) in pilot experiments revealed 1-2 mV of depolari zation in rat main pulmonary artery.
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2.2. Study II. Influence of high salt diet on p-adrenoceptor signalling
2.2.1. Prepara tion of anima ls
At four weeks of age male Sprag ue Daw ley rats were housed (two per cage) with 12h
light/dark cycles and given access to either normal diet (0.26% Na, 0.44 % Cl; LabDiet
5POOProLab, PM I Nutrition International, Brentwood, MO, U.S.A) or high salt diet
(1.52 % Na, 2.4 1% CI; Modified LabDiet 500 1; PMI Nutri tion International, Brentwood ,
MO, U.S.A) along with tap wate r ad libitum for 18 - 23 days.
2.2.2. Blood pressure and heart rate measurements
Follow ing 18 - 23 days on either diet, each rat was anaes thetised with halothane (5% in
100% oxyge n for induction and 1.25% in 100% oxyge n for maintenance) and a cathet er
(polyethylene tubing ID 0.28 mm, OD 0.6 Imm) was inserted into the left distal femoral
artery for the measurement of blood pressure and heart rate . The cathete r was filled with
heparinised saline (25 i.u.lml in 0.9% NaCl), and the blood press ure and heart rate were
measured for 10-15 min continuously. Arter ial blood pressure was recorded with a
pressure transducer (Gould Statham, U.S.A.; Model PD23B) . The pressure transducer
was connec ted to an amplifier (DA 100A) that in turn was linked to a universal interface
modul e (UIM 100) which then interfaced with an acquisi tion unit (MP 100) (Bieger et 01.,
2004) .
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2.2.3 . Electro lyte measurements
Before sac rificing eac h anima l, a 1.0 ml arter ial blood sample was taken for the
measurement of electro lytes . Each blood sample was centrifuge d in an Eppe ndorf
centrifuge , Model 54 15C (14000 rpm) for 6 min to separa te serum from ce lls.
Approx imately of 500 III of serum was collected and electro lytes were measured using a
Beckm an Co ulter LX20 Pro.
2.2.4. T issue isol ation
The study was perfor med using only intact blood vesse ls from rats fed eit her a regular or
high salt diet. The procedur e describ ed in 2. 1.2. was followe d, briefly car diopulmonary
orga ns we re transferred into a dissectin g dish containing physiological buffer (pH 7.4)
satura ted with a 95% O2: 5% CO2 gas mixture at 36 ± 1 °C. The main left and right
pulm onary arteries were isol ated , dissected free of connec tive tissue and separa ted from
the pulm onary trunk. The right ventricle and left ventricle plu s septum were separated,
and the wet we ights of the heart s were recorded. The ventricles were then placed in an
ove n, heated (500 C) for 6 h, and the dry weight was also recorded.
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2.2.5. Experimental protocol
2.2.5.1. Mec hanica l force measurements
The protocol describ ed in 2. 1.3.1. was followed, briefly pulm onary artery rings were
mounted in 20 ml organ baths under a force of9 .8 mN. The artery rings were contracted
with phenylephrin e (1.0 IlM ) and integrity of endothelial cells was ascertained by
relaxing them with meth acholine (1.0 IlM ). Tissues were washed with physiological
buffer . Following equilibration for an additional 60 minut es, tissues were contra cted with
phenylephrin e (0.3 IlM - I IlM ) in order to construct cumul ative response curve to
isoprenaline (1.0 nM - 30 IlM ) in the absence and presence of vehicle, acidic buffer, N"'-
nitro-L-arginin e-methyl ester (10 IlM ; nitric ox ide synthase inhibitor, L-NA ME), barium
chloride (100 IlM ), ouabain (100 IlM ), adenosine- 3', 5'- cyclic monophosphorothioate,
Rp- isomer (30 IlM ; cAMP antagonist, Rp-cAMP), tetraethylamm onium (3.0 mM; TEA)
or combin ation of these interventions i.e. buffer pH 6.4 plus BaCh (100 IlM ), buffer pH
6.4 plus L-NAM E (10 IlM ), buffer pH 6.4 plus Rp-cAMP (30 IlM ), BaCh (100 IlM) plus
ouabain (100 IlM ), buffer pH 6.4 plus BaCh (100 IlM ) plus ouabain (100 IlM), BaCh
(100 IlM ) plus ouabain ( 100 IlM ) plus TEA (3.0 mM), pH 6.4 plus BaCh (100 IlM ) plus
ouabain (100 IlM ) plus TEA (3.0 mM).
67
2.2.5.2. Membr ane potent ial measurement s
The protocol describ ed in 2.1.3.2. was follow ed, briefly pulm onary artery rings were held
under the tension of9.8 mN in a 5 ml sylgard lined tissue chamber perfused with
physiological salt solution pregassed with a mixture of 95% 0 2 : 5% CO2 delivered at a
rate of3-4 ml per min and warmed to 34-35°C. The Emwas recorded with borosilicate
capill ary microel ectrod es filled with KCl (3.0 M) with a tip resistance of 10-20 MD .
Initially, the Emfrom 3-6 cells was recorded prior to exposure of the blood vesse ls to
acidic buffer, N"'-nitro-L- arginin e-methyl ester (10 11M), BaCh (100 11M), ouabain (100
11M), tetraethylamm onium (TEA; 3.0 mM) or combin ation of these interventions i.e.
buffer pH 6.4 plus BaCh (100 11M), buffer pH 6.4 plus L-NAM E (10 11M), BaCh (100
11M) plus ouabain (100 11M), buffer pH 6.4 plus BaCh (100 11M) plus ouabain (100 11M),
BaCh (100 11M) plus ouab ain (100 11M) plus TEA (3.0 mM), pH 6.4 plus BaCh (100 11M)
plus ouabain (100 11M) plus TEA (3.0 mM). Subsequently, tissues were exposed to
solutions contain ing isoprenaline (1.0 11M) for 5-10 min , and the Emof the cells was
sampled.
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2.3. Study III. Effect of denudation of endothelium on vascular p-adrenoceptor
signalling in rats fed a high salt diet.
2.3.1. Preparation of animals
Male Sprague Dawley rats, four weeks of aged were housed (two per cage) with 12h
light/dark cycles and given access high salt diet (1.52% Na, 2.4 1% CI; Modified LabDiet
5001; PMI Nutrit ion Internation al, Brentwood , MO, U.S.A) and tap water ad libitum for
18 - 23 days.
2.3.2. Blood pressure and heart rate measurements
The procedure detailed in 2.2.3. was followed.
2.3.3. Tissue isolation
The protocol described in 2.1.2. was followed.
2.3.4. Experimental protocol
2.3.4.1. Mechanical force measurements
The protocol mention ed in 2. 1.3.1. was followed excluding experiments involving TEA
alone and in combination.
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2.3.4.2. Membrane potential measurements
The protocol mentioned in 2.1.3.2. was followed excluding experiments involving TEA
alone and in combin ation.
2.4. Data and Statistical Analysis
Results from the relaxation studies were calculated as a percentage of the maximum
relaxation induced by isoprenaline following contraction with phenylephrin e. Percent
maximal response (Emax) and pECsovalues were calculated for individual curves with
help of statistical software, Sigma Plot 8.0. An analysis of variance was used for
statistical analysis of the data. The Student Newman-Keuls mult iple range test was used
for multipl e comparisons between means. Student's t-test was also used to compare
means. For all cases, a probability of error of less than 0.05 was selected as the criterion
for statistical significance.
2.5. Chemicals
Stock solutions of all drugs were made in twice-distilled water. All drugs were purchased
from Sigma Life Science (Oakville, Ontario, Canada).
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3.0. RESULTS
3.1. Study I. Role of endothelium in vascu lar p-adrenoceptor signalling
3.1.1. Mechanical Function
3.1.1.1. Intact tissues
Isoprenaline produced concentrat ion-dependent relaxations with Ell/ ax and pECso of 82.83
± 1.00% and 7.26 ± 0.02, respectively (mean ±s.e.m.; n = 87). The relaxant responses to
isoprenaline were significantly attenuated in acidic buffer and BaH alone, where Ell/ ax and
pECso were reduced (Table 2; Figure 2B and 3A). The presence of TEA (3.0 mM) or
ouabain (100 11M) alone elicited modest but statistically significantly inhibition of
relaxant responses to isoprenaline (Table 2; Figures 4A and SA). The inhibiti on of the
isoprenaline-evoked relaxant responses produced by TEA or ouabain alone was
significantly lower compared to acidic buffer and Ba2+ alone (Table 2). Inclusion of BaH,
TEA or ouabain alone in acidic buffer did not produce further inhib ition of isoprenaline
relaxant responses compar ed to acidic buffer or Ba2+ alone (Table 2; Figure 3B, 4B and
SB). Presence of TEA and Ba2+ combined in acidic or regular buffer did not cause further
inhibition compared to acidic buffer alone (Table 2; Figure 6A and B). Inhibition of
isoprenaline mediated maximal responses, produced by Ba2+ and ouabain combined in the
absence or presence of TEA was of similar magnitude (Table 2; Figure 7A and 8A).
However , in the presence of acidic buffer, Ba2+ and ouabain combined or BaH, ouabain
and TEA combin ed caused further inhibition of relaxant responses produced by
isoprenaline (Table 2; Figure 7B and 8B).
Tab le 2. Percent maximal response (Emax) and pECsodetermined from individual concentration-response curves for isoprenaline
in rat main pulmonary artery ring preparations with (+E) and without (-E) endothelium .
pECso
Regular diet (+E)
e.: pEC50
Regular diet (-E)
Emax
Control 7.24 ± 0.11 77.00 ± 3.81 7.16 ± 0.08 61.00 ± 4.29
Acidic buffer 6.91 ± 0.08",d 54.33 ±4.42" 6.83 ± O.l l ",e 54.00 ± 6.30
Control 7.26 ± 0.05 80.33 ± 5.76 7.01 ± 0.09 62.17 ± 4.77
BaCb 6.87 ± 0.09",b 42.00 ± 4.14",b 7.00 ± 0.09 50.33 ± 5.41"
Control 7.15 ± 0.14 85.50 ± 1.91 7.17 ±0.10 63.17 ±6.53
Acidic buffer + BaCb 6.69 ± 0.12" 58.00 ± 4.12",d 6.78 ± 0.22 56.67 ± 2.73
Control 7.30 ± 0.07 78.33 ± 1.82 7.10 ± 0.05 63.00 ± 4.52
TEA 7.10 ± 0.04" 68.00 ± 2.88"'b,d 6.69 ± 0.31 51.17 ±9.54"
Control 7.28 ± 0.09 77.83 ± 6.29 7.05 ±0.13 68.00 ± 3.56
Acidic buffer + TEA 6.78 ± 0.19 49.83 ± 4.89" 6.52 ± 0.4ge 55.33 ± 4.17"
Control 7.29 ± 0.08 86.83 ± 1.70 6.91 ± 0.07 69.83 ± 6.49
Ouabain 6.84 ±0.10" 72.83 ± 3.34",b,d 6.54 ± 0.28 58.67 ± 5.57
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Control 7.24 ± 0.12 82.83 ± 2.15 7.18 ± 0.08
Acidic buffer + ouabain 6.77 ± 0.07" 60.67 ± 7.363 6.85 ± 0.073
Control 7.33 ±0.09 80.83 ± 3.90 7.18 ± 0.12
TEA + BaCh 6.96 ± 0. 11 51.17± 8.063 6.99 ± 0.03
Control 7.39 ± 0.08 86.50 ± 4.86 7.14 ± 0.25
Acidic buffer + TEA + BaCh 6.94 ± 0.19 52.17± 7.383 6.87 ±0.12
Control 7.19 ± 0.07 85.38 ±3 .66 6.98 ± 0.06
BaCh + Ouabain 6.77±0. 113 44.00 ± 5.013 6.80 ± 0.07
Control 7.19 ± 0.08 80.50 ± 2.95 7.19 ± 0.05
Acidic buffer + BaCh 6.62 ± 0.083 33.00 ± 5.393 ,b 6.65 ± 0.193
+ Ouabain
Control 7.35 ± 0.06 87.33 ± 2.94 6.69 ± 0.22
BaCh + Ouabain + TEA 6.72 ±0.173 43.83 ± 8.87" 6.48±0.26
Control 7.29 ± 0.06 84.17± 3.89 6.72 ± 0.26
Acidic buffer + BaCh + 6.32 ±0.173 ,d 26.00 ± 5.033 ,b,d 6.49 ± 0.03c
Ouabain + TEA
Acidic buffer (pH 6.4 ± 0.2) BaCh (100 11M); Ouabain (100 11M); Tetraethylammonium (TEA, 3.0 mM)
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54.17 ±5.69
49.50±3.20
65. 17± 5.56
57.50 ± 5.39
69.00 ± 7.89
46.83 ± 8.123
67.33 ± 3.99
37.33 ± 10.403
67.17± 7.71
48.17 ± 7.283
58.33 ± 3.49
24.67 ± 7.203 ,c,c
60.33 ±6.41
21.17± 4.083 ,c,c
Each value is the mean ± s.e.m., n= 6-8
'Significantly different from respective control;p <0.05
bSignificantly different from acidic buffer (intact ); p<O.05
'Significantly different from acidic buffer (denuded); p<0.05
"Significantl y different from BaCh (intact); p<O.05
<Significantly different from BaCh (denuded); p<O.05
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Figure 2. Concentration-response curve for isoprenaline (% relaxation remaining from phenylephrin e induced sub-maximal
contractions) in intact {+E} and denuded {-E} main pulmonary artery ring preparations from rats fed a regular diet [R] in A)
regular buffer (control) and twice-distilled water and; B) regular buffer (control) and acidic buffer. Each point represents a mean
± s.e.m. of six to seven experiments.
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Figure 3. Concentration-response curve for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal
contractions) in intact {+E} and denuded {-E} main pulmonary artery ring preparations from rats fed a regular diet [R] in A)
regular buffer absence (control) or presence of BaCh and; B) regular buffer (control) or acidic buffer plus BaCh. Each point
represents a mean ± s.e.m. of six experiments.
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Figure 4. Concentration-response curve for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal
contractions) in intact {+E} and denuded {-E} main pulmonary artery ring preparations from rats fed a regular diet [R] in A)
regular buffer absence (control) or presence of TEA and; B) regular buffer (control) or acidic buffer plus TEA. Each point
represents a mean ± s.e.m. of six experiments.
76
77
3.1.1.2. Denuded tissues
Isoprenaline produ ced concentration-dependent relaxations with Emax and pECsoof63 .76
± 1.57% and 7.03 ±0.04, respectively, (mean ± s.e.m.; n = 84) which were significantly
smaller when compared to intact blood vessels. Denudation effectively attenuated the
relaxant responses to isoprenaline (Table 2; Figure 2A). Acidic buffer did not cause
inhibition of relaxation to isoprenaline (Table 2; Figure 2B). TEA , Ba2+or ouabain alone
also did not cause inhibit ion of relaxant responses to isoprenaline (Table 2; Figure 3A, 4A
and 5A). Inclusion of Ba2+, TEA or ouabain alone in acidic buffer did not cause further
inhibition of relaxation to isoprenaline when compared to their respective control or
acidic buffer (Table 2; Figure 3B, 4B and 5B). The combination of Ba2+ and TEA also did
not result in further inhibiti on compared to TEA and ouabain alone (Table 2; Figure 6A).
In contrast, Ba2+ and ouabain combined produced significant inhibiti on of the relaxant
responses to isoprenaline compared to Ba2+or ouabain alone. The inhibitory effect of
Ba2+ and ouabain combined in denuded tissue was similar to intact tissues (Figure 7A).
The presence of TEA and Ba2+ combined, or Ba2+ and ouabain combined, in acidic buffer
did not cause further inhibition compared to acidic buffer alone (Table 2; Figure 6B and
7B). While the combi nation of Ba2+, TEA and ouabain in regular or acidic buffer
produced additive inhibition compared to acidic buffer and Ba2+alone, the inhibition
produced by the former intervention was not different from the effect of Ba2+, TEA and
ouabain combined in the regular buffer (Table 2; Figure 8A and 8B).
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Figure 5. Concentration -response curve for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal
contractions) in intact {+E} and denuded {-E} main pulmonary artery ring preparations from rats fed a regular diet [R] in A)
regular buffer absence (control) or presence of ouabain and; B) regular buffer (control) or acidic buffer plus ouabain. Each point
represents a mean ± s.e.m. of six experiments .
78
120A -+- conlroIIRI I+E}(n=6)
---{)-TEA (3mM) +BaCI, (I00I1M)IRj {+E}(n=6)
--.- conlroI IRj l·E}(n=6)
-A- TEA(3 mM) + BaCl,(IOO11M) IRj {-E}(n=6)
120
B -+- conlroljRj l+E}(n=6)
---{)- bufferpIl 6.4+TEA (3mM) +BaCl,(I00I1M)IRj {+E}(n=6)
--'- conlrol jRj l-E}(n=6)
-V- bufferp1l6.4 + TEA(3 m~l) + BaCl,(I00 I1M)lRI{-E}(n=6)
0_....
9
-----'------'-------'------'
Log[Isoprenaline](l\I)
O .L...~__---'-__----L__-....JL-.-_----I
Log[Isoprenaline](l\I)
Figure 6. Concentration-response curve for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal
contraction s) in intact {+E} and denuded {-E} main pulmonary artery ring preparations from rats fed a regular diet [R] in A)
regular buffer absence (control) or presence of TEA and BaCh together and ; B) regular buffer (control) or acidic buffer plus
TEA and BaCh together. Each point represents a mean ± s.e.m. of six experiments.
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Figure 7. Concentration -response curve for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal
contractions) in intact {+E} and denuded {-E} main pulmonary artery ring preparation s from rats fed a regular diet [R] in A)
regular buffer absence (control) or presence of BaCh and ouabain together and; B) regular buffer (control) or acidic buffer plus
BaCh and ouabain together. Each point represents a mean ± s.e.m. of six to eight experiments.
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Figure 8. Concentration-response curve for isoprenaline (% relaxation remaining from phenylephrin e induced sub-maximal
contractions) in intact {+E} and denuded {-E} main pulmonary artery ring preparations from rats fed a regular diet [R] in A)
regular buffer, absence (control) or presence of BaCb, ouabain and TEA together ; B) regular buffer (control) or acidic buffer
plus BaCb ouabain and TEA together. Each point represents a mean ± s.e.m. of six experiments.
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3. 1.2. Membrane potential
3.1.2. 1. Intact tissue
Acidic buffe r, TEA or ouabain alone did not ca use significa nt changes in the rest ing Emof
the smoo th muscle ce lls (-61.3 ± 1.24, -60.5 ± 1.32, -58 .7 ± 0.53 mVr espectively; Tab le
3). However , BaH in the absence or presence of ac idic buffer ca used mode st
depolari sati on of the vascul ar smoo th muscle cell s (-57.7 ± 0.38, -57 .5 ± 0.26 respecti vely
mY ; Tabl e 3) . BaH and ouabain combined, but not BaH and TEA combined, depol ari zed
pulmonary artery smo oth muscle cells (-58.7 ± 0.9, -60. 5 ± 0.85 mV respecti vely ; Table
3). Addition of the latter two agent s to acidic buffer (-58.2 ± 0.35, -57. 6 ± 0.94 mY)
resulted in mode st but significant depolarization comp ared to ac idic buffer alone (-6 1.3 ±
1.24 mY) but not more than Ba2+ alone (-57.7 ± 0.38 mY) (Ta ble 3) . Similarly, the
presenc e of Ba2+, TEA and ouabain in acidic buffer (-56.4 ± 0.54 mV) or in regular buffer
(-55 .9 ± 0.86 mY ) result ed in further depolari zation compare d to acidic bu ffer alone (-
61.3 ± 1.24 mY ) (Ta ble 3) . Howe ver, the additi on of acidic buffer failed to increase the
inhibitory effect of combined inte rventi ons (BaH, TEA and ouabain) . Expos ure of
isopren aline to blood vesse ls result ed in hyperpolari sation of approx imate ly 8.0 mV
(Ta ble 3). The hyperpolari sation produced by isopren alin e was significantly dimini shed
in acidic buffer (-61.3 ± 1.24 vs -64 .2 ± 1.29 mY , respectively; Table 3). TEA mod estly
but not significantly inhibited isopren aline induced hyperp olari zation (-60 .5 ± 1.32 vs-
64.2 ± 1.37 mY , respectiv ely ; Table 3) . Further , inclu sion of acidi c buffer with TEA
caused additive inhibiti on (-58.3 ± 1.12 vs -59.5 ± 1.38 mY , respectivel y; Ta ble 3).
Presence of Bi +or ouabain alone in regular buffer did not affec t isoprenaline-evoked
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hyperpolarisation (-58.7 ± 0.97 vs -64 .1 ± LIS mY, respectively; Table 3). However, in
the presence of acidic buffer ouabain (-59 .3 ± 1.31 mY) but not Ba2+(-57.5 ± 0.26 mY)
alone, dimini shed isoprenaline induced hyperpolarisation (Table 3). Isoprenaline
mediated hyperpolarization was partially inhibited by exposure of Ba2+and TEA
combined (-60. 5 ± 0.85 vs -65.5 ± 1.70 mY, respectively), or Ba2+ and ouabain combined
(-58. 7 ± 0.97 vs -64.1 ± 1.15 mY, respectively) (Table 3). Isoprenaline-indu ced
hyperpolarisation was similarly affec ted by Ba2+, ouabain and TEA together in regular (-
55.9 ± 0.86 vs -57 .7 ± 0.81 mY, respectively) or acidic buffer (-56 .4 ± 0.54 vs -58.3 ±
0.62 mY, respectively; Table 3).
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Table 3. Membrane potential (mV) in vascular smooth muscle cells of rat pulmonary ring preparation with (intact) and without
(denuded) endothelium in absence or presence of isoprenaline (1.0 11M)after various treatments.
Regular diet (+E) Regular diet (-E)
Control Treatment Isoprenaline Control Treatment Isoprenaline
No treatment -62.2 ± 1.27 -70.6 ± O.72a -68.2 ± 0.27b -69.6± 1.I8 b
(8)(34) (8)(41) (6)(25) (6)(35)
Acidic buffer -61.6 ± 1.04 -61.3 ± 1.24 -64.2 ± 1.29 -67.1 ± 0.52b -66.2± 1041 -63.9 ± 1.84 (4)
(5)(24) (5)(24) (5)(21) (9) (44) (7) (31) (23)
TEA -61.8 ± 0.72 -60.5 ± 1.32 -64.2± 1.37c -68.5 ± 1.25b -64.9 ± 0.95 -66.5 ± 1.19
(4)(17) (4)(24) (4)(26) (8)(30) (7)(34) (4)(22)
BaCh -60.7 ± 1.21 -57.7 ±0.38a -64.1 ± 1.56a,c -68.1 ±OA5 b -66A ± 1.01 -64.2 ± 1.72 (4)
(4)(23) (4)(18) (4)(25) (8)(36) (6)(31) (22)
Ouabain -6004± 0.56 -58.7 ± 0.53 -64.9 ± 0.51c -69.1 ± 1.43b -61.7 ± 1.I4 a -59.2 ± 1.79a
(4)(24) (4)(25) (4)(23) (5) (12) (4) (22) (8) (22)
Acidic buffer + TEA -60.1 ± 0.99 -58.3 ± 1.12 -59.5 ± 1.38 -66.8 ± 0.67b -61.9 ± 1.78a -6204± l.92 a
(4)(15) (4)(19) (4)(19) (5)(35) (4)(23) (4)(22)
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Acidic buffer + BaCh -61.5 ± 0.78 -57 .5 ± 0.26a -64 .8 ± 0.69 a,< 67 .2 ± O.72b -63 .9 ± 0.32a -62.6 ± 1.27"
(4)(23 ) (4)(23) (4)(18) (7)(35) (5)(26) (4) (19)
Acidic buffer + -60.8 ± 0.49 -59.3 ± 1.31 -63.5 ± 1.64 -68.5 ± i.ss" -61. 7 ± 1.76a -59 .3 ± 1.88a
Ouabain (4)(24) (4)(24) (4)(22) (4)(19) (4) (22) (4)(19)
BaCh + TEA -60.6 ± 0.28 -60.5 ± 0.85 -65.5 ± 1.70a,< -67.4 ± 1.69b -63 .1 ± 1.48a -6 1.7 ± 1.82a
(4)(17) (4)(17) (4)(24) (4)(1 1) (4)(19) (4)( 19)
BaCh + Ouabain -61.2 ± 0.48 -58 .7 ±0.97a -64.1 ± 1.15a,< -70.3 ± 1.32b -58.3 ± 1.20a,e -60 .7 ± 1.19a
(4)(22) (4)(22) (4)(20) (4)(1 1) (4) (23) (4)(22)
Acidic buffer + BaCh -61.8 ± 0.49 -57.6 ± 0.94 a,d -60.1 ± 1.82 -68 .5 ± 1.89b -63.0 ± 1.39a -61.3 ± 1.41a
+ TEA (4)(10) (4)(19) (4)(14) (3)(10) (4)(19) (4)(19)
Acidic buffer + BaCh -62.2 ± 0.2 1 -58.2 ± 0.35a,d -61.3 ± 1.55 -68.7 ± 2.19b -58.5 ± O.73a,e -61.2 ±0.87"
+ Ouabain (4)(22) (4)(21) (4)(22) (4)(9) (4)(23) (4)(23)
BaCh + Ouabain -60.8 ± 1.37 -55.9 ± 0.86a,d -57.7± 0.81 -66.5 ± 0.50b -56 .8 ± 1.67a,e -61.3 ± 1.38a
+ TEA (4)(16) (4)(26) (4)(24) (4)(9) (4)(27) (4)(23 )
Acidic buffer + BaCh -61.3 ± 1.01 -56.4 ± 0.54a,d -58 .3 ± 0.62a -67.3 ± 1.01b -58 .6 ± 1.59",e -61.7 ± 1.35a
+ Ouabain + TEA (4)( 15) (4)(2 1) (4)(24) (4)(7) (4)(2 1) (4)( 15)
Acidic Buffer (pH 6.4 ± 0.2); Tetraeth ylamm onium (TEA ; 3.0 mM ); BaCh (100 11M); Ouabain (100 11M)
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Each value is the mean ± s.e.m. with the numbe r of cells and number of rats indicated in parenthes es
'Significantly different from respective control ; p <O.05
bSignificantly different from contro l (intact); p<O.05
<Significantly differ ent from respective treatment ; p<O.05
dSignificantl y different from acidic buffer (intact);p <0.05
<Significantly different from acidic buffer (denuded); p<O.05
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3. 1.2.2. Denud ed tissue
The resting Emof smoo th muscle cells of denud ed blood vesse ls (-E) was significantly
different from that of intact blood vesse ls (+E) (-62 .2 ± 1.27 vs -68.2 ± 0.27 mY,
respectively; Table 3). The cells were hyperpolarized by approx imately 6-8 mY in
denuded comp ared to intact blood vesse ls. Neither acidic buf fer (-67.1 ± 0.52 vs -66.2 ±
1.41 mY, respectiv ely) nor Ba2+ alone (-68.1 ± 0.45 vs -66.4 ± 1.01 mY, respectively)
influenced the restin g EII/' In contrast, ouabain (-69. 1 ± 1.43 vs -61.7 ± 1.14 mY,
respectively) but not TEA alone (-68.5 ± 1.25 vs-64.9 ± 0.95 mY, respecti vely) caused
significant depolari zation of the vascular smooth muscle cells (Table 3). Howe ver, the
inclusion ofBa2+(-67.2 ± 0.72 vs -63.9 ± 0.32 mY, respectively) TEA (-66 .8 ± 0.67 vs -
6 1.9 ± 1.78 mY, respectively) or ouabain alone (-68.5 ± 1.85 vs -61.7 ± 1.76 mY,
respectivel y) in acidic bu ffer also caused significant depolarization of the Em. As well ,
the combination of Ba2+ and TEA, Ba2+ and ouabain, and Ba2+, TEA and ouabain in
regular or acidic buffer also depolarized the smooth muscle cells (Table 3). Isoprenaline-
induced hyperp olarization was notably absent in these tissues with or without any
interve ntion (Table 3).
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Table 4. Systolic and diastolic blood pressure (BP; mmHg); heart rate (HR ; beats/min) ;
body weight (BW; g) and ratio of right ventricle dry (RVd) to wet (RV,,) weight ; ratio of
left ventricle + septum , dry (LV + Sd) to wet (LV + Sw)weight of rats fed a regular and
4% salt (NaCI) diets for 18-23 days.
DP HR DW RVd/R V" LV+Sd/
LV+Sw
Regular diet 94/70± 368±4.20 295±3 .23 0.21 ± 0.01 0.29 ±0.01
0.6 1/0.78 (77) (77) (77) (4 1) (4 1)
4% Salt diet 106/72 ± 378±3.77 282±3.74" 0.2 1 ± 0.01 0.28 ± 0.01
0.94"/0 .68" (83) (83) (83) (4 1) (41)
"Significantly different from respective value in regular diet group ;p < 0.05.
Each value represents a mean ± s.e.m. ; number of rats indicated in parenthesis.
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3.2. Study II. Influ en ce of high salt diet on p-adren ocept or signalling
Blood pressure (systolic and diasto lic) of rats on high salt diet was modestly but
significa ntly higher than rats on regular diet while heart rates among the two groups were
not significa ntly different (Tab le 4). A significantly lower body weight was record ed for
rats on high salt diet compared to those on a regular diet (Tab le 4). The ratio of wet to
dry weight of left and right ventricles was found not to be different between the two
groups of rats (Ta ble 4) i.e. no left or right ventricular hypertroph y was apparent. The
values of serum electrolytes were also not different between the two groups of rats (Table
5).
3.2.1. Mechanica l Function
Relaxations produced by isoprenaline in pulmonary arteries from rats on regular and high
salt diets were of simi lar magnitude in terms of Emax and pECso(84 .16 ± 1.08% and 7.24±
0.03 vs. 83.34 ± 1.09% and 7.23 ± 0.03; n = 65) , respectively. Addition of twice disti lled
wate r did not affec t the cumulative concentration-response curves to isoprenaline in
tissues from rats fed a regular compared to the salt diet (Figure 9A, IDA, II A). Acidic
buffer (pH 6.4) attenuated isoprenaline-induc ed responses, significa ntly reducing Emax
and pECso(Figure 9B, IDB, II B). The latter intervention produc ed a significantly grea ter
inhibi tion of the relaxan t response to isopre naline in blood vesse ls obtained from rats on
high salt compared to regular diet (Figure liB, Table6) . The effec ts of the cAMP
antagonist, Rp-cAMP, on relaxant responses to isoprenaline were similar as in the
previous findin gs
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Figure 9: Concen trat ion-response curve for isoprenal ine in main pulmonary artery ring
preparation from rats fed regular diet [R] of A) in regular buffer (contro l), B) in buffer pH
6.4, C) in the presence barium chloride (100 11M)plus ouabain (100 11M) and, D) buffer
pH 6.4 plus barium chloride (100 11M) plus ouabain (100 11M).
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Table 5. Serum electrolyte s (mmol/ I) of the rats fed regular diet and 4% salt diet for 18-
23 days.
Regular diet 4% Salt diet
Na+ 137.69 ±0.39 136.81 ± 0.38
K+ 4.48 ±0.08 4.67 ± 0.10
cr 98.44 ± 0.47 98.19 ± 0.33
Ca2+ 2.49 ±0.02 2.53 ± 0.02
Each value represents a mean ± s.e.m., n=16
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from our laborator y (Bieger et ai, 2006), and of similar magnitude in tissues from rats on
a high salt or a regular diet.
L-NAME (10 /-1M) significantly reduc ed Emax and pECso of isoprenaline concentration-
response curves in tissues from rats on regular diet. In contr ast, L-NA ME only caused a
modest but significant reduction in Emax without affec ting the pECso in tissues from rats
on high salt diet (Ta ble 6; Figure 12A). The inclusion of L-NA ME in acidic buffer
resulted in a significant reduction in Emax and pECsofor isoprenaline. The inhibit ory
effect ofL-NAME in acidic buffer was modestly but significantly greater in tissues from
rats on high salt compared to the regular diet (Table 6; Figure 12B). The presence of BaH
(100 /-1M) significantly attenuated isoprenaline-induc ed relaxations and this effect was of
similar magnitud e in blood vesse ls from rats fed either regular or a high salt diet (Table 6;
Figure 13A). The inclusion of Ba2+ in the acidic buffer caused a significantly greate r
inhibition of the isoprenaline relaxations in pulmonary arteries from rats on high salt
compared to those on a regular diet (Table 6; Figure 13B).
The presence of Ba2+ and ouabain together produc ed additional inhibiti on of isoprenaline-
induced relaxation s when comp ared to BaH alone in the tissues from rats on a high salt
diet (Table 6; Figure 9C, 10C, 13A and 14A). It was apparent that Ba2+ and ouabain
togethe r produced a greater inhibitor y effect in tissues from rats fed a high salt in
comparison to the regul ar diet (Figure 14A). Howev er, the inclusion of Ba2+ and ouab ain
together in acidic buffer resulted in similar inhibition of isoprenaline responses in tissues
from both rats on a high salt diet and those on a regular diet (Table 6; Figure 9D, 10D,
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14B). Toge ther, TEA (3.0 mM), Ba2+ and ouabain produced significantly greater
inhibit ion of isoprenaline
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Figure 10: Concentratio n-respo nse curve for isoprenaline in main pulmonary arte ry ring
preparatio n from rats fed 4% salt diet IS] A) in regular buffer (con tro l), B) in buffer pH
6.4, C) in the presence of barium chloride (100 11M)plus ouabain (100 ~lM) and, D)
buffer pH 6.4 plus barium chloride (100 11M) plus ouabain (100 11M).
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evoked relaxation in tissues from rats on high salt compared to regular diet, while in the
acidic buffer, these pharmacological agents (i.e. TEA, Ba2+ & ouabain, together)
produced similar inhibition of isoprenaline-induced relaxations in blood vesse ls of rats
on either diet (Figure 1SA and B).
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Table 6. Percent maximal response (Emax ) and pEC 50 determined from individual concentration-response curves for isoprenaline
in main pulmonary artery ring preparations from rats fed regu lar diet and 4% salt diets for 18-23 days .
Regular diet 4% Salt diet
pEC 50 e.: pEC 50 e.:
Control 7.21 ± 0.06 85.00 ± 3.02 7.11 ± 0.15 88.14±3.25
200 IlLdd H2O 7.16±0.07 79.29 ± 2.01c.e 7.42 ± 0.09f 86.86 ±5.35d,f
Control 7.24±0.11 77.00 ± 3.81 7.29 ± 0.02 79.17±3.48
Acidic buffer 6.91 ± 0.08 " 54.33 ± 4.42" 6.70 ±0.19" 43.00 ± 3.53"·b
Control 7.36 ± 0.15 87.86 ± 4.06 7.50 ± 0.05 88.43 ±2.92
L-NAME 6.88±0.11" 66.71 ± 4.40",c,e 7.18 ±0.09 73.71 ± 3.19",d,f
Control 7.25 ± 0.06 87.14 ±2.32 7.25 ± 0.05 79.83 ± 5.89
Acidic buffer + L-NAME 6.74±0.081" 53.00 ± 5.26" 6.52±0.23" 39.33 ± 3.64",b
Control 7.26 ± 0.05 80.33 ± 5.76 7.15 ± 0.07 78.17±2.26
BaCh 6.87±0.09" 42.00 ± 4.14" 6.98 ± 0.05 48.50 ±3.03"
Control 7.15 ± 0.14 85.50 ± 1.91 7.18 ± 0.11 85.67 ± 1.14
Acidic buffer + BaCh 6.69 ± 0.12" 58.00 ± 4.12",e 6.52 ± 0.06"·f 47.33 ±2.73"·b
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Control 7.l9 ±0.07 85.38 ±3.66 7.30 ± 0.05 87.88 ± 2.05
BaCh + Ouabain 6.77 ±0.lla 44.00 ±5.0I a 6.83 ± 0.14a 27.88 ± 3.62a,b,d,f
Control 7.l9 ±0.08 80.50 ± 2.95 7.25 ±0.07 81.67±3.58
Acidic buffer + BaCh + Ouabain 6.62 ± 0.08a 33.00 ±5.39a,c 6.46 ± 0.13a,d,f 37.83 ±2.83a,d,f
Control 7.35 ±0.06 87.33 ± 2.94 7.26 ± 0.09 81.71 ± 3.05
BaCh + Ouabain + TEA 6.72 ±0.17a 43.83 ± 8.87a 6.63 ± 0.07a 23.86±5.63a,b,d,f
Control 7.29 ±0.06 84.17±3.89 7.14±0.04 79.71 ± 4.17
Acidic buffer + BaCh + Ouabain 6.32 ±0.17a,c 26.00 ± 5.03a,c,e 6.32 ± 0.19a,d,f 21.86 ± 2.93a,d,f
+ TEA
Acidic buffer (pH 6.4 ± 0.2); N"'-nitro-L-arginine-methyl ester (L-NAME ; 10 11M); BaCh (100 11M); Ouabain (100 11M);
Tetraethylammonium (TEA, 3.0 mM).
Each value is the mean ± s.e.m., n= 6-8
"Significantly different from respective control ; p <0.05
bSignificantly different from treatment (regular diet) ;p<0.05
"Sigrrifcantly different from acidic buffer (regular diet); p <O.05
dSignificantly different from acidic buffer (4%Salt diet);p<0.05
"Significantly different from BaCh (regular diet) ; p <0.05
fSignificantly different from BaClz (4%Salt diet) ; p <O.05
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Figur e 11. Concentration- response curve for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal
contractions) in main pulmonary artery ring preparations from rats fed a regular [R] or 4% salt [S] diets for 18-23 days in A)
regular buffer (control) and twice-distilled water and; B) regular buffer (control) and acidic buffer. Each point represents a mean
± s.e.m. of six to seven experiment s. ' Significantly different from respective value of regular diet;p<O.05.
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Figu re 12. Concentration-response curve for isoprena line (% relaxation rema ining from pheny lephrine induced sub-maximal
contractions) in main pulmonary artery ring prepa rations from rats fed a regular [R] or 4% salt [S] diets for 18-23 days in A)
regular buffer absence (control) or presence ofL-NAME and; B) regular buffer (contro l) or acidic buffer plus L-NAME . Each
point represents a mean ± s.e.m. of six to seven experiments. ' Significantly different from respective value of regular diet ;
p<O.05.
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Figure 13. Concentration -response curve for isoprenaline (% relaxatio n remaining from pheny lephrine induced sub-maximal
contractions) in main pulmonary artery ring preparations from rats fed a regular [R] or 4% salt [S] diets for 18-23 days in A)
regular buffer absence (control) or presence of BaCh and; B) regular buffer (control) or acidic buffer plus BaCh. Each point
represents a mean ± s.e.m. of six experiments. ·Significantly different from respective value of regular diet;p<O.05.
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Figure 14. Concentration-response curve for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal
contractions) in main pulmonary artery ring preparations from rats fed a regular [R] or 4% salt [S] diets for 18-23 days in A)
regular buffer absence (control) or presence of BaCh and ouabain together and; B) regular buffer (control) or acidic buffer plus
BaCh and ouabain together. Each point represents a mean ± s.e.m. of six to eight experiments. 'S ignificantly different from
respective value of regular diet; p<O.05.
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Figure 15. Concentration -response curve for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal
contractions) in main pulmonary artery ring preparations from rats fed a regular [R] or 4% salt [S] diets for 18-23 days in A)
regular buffer, absence (control) or presence of BaClz, ouabain and TEA together; B) regular buffer (control) or acidic buffer
plus BaCh ouabain and TEA together. Each point represents a mean ± s.e.m. of six to seven experiment s. ' Significantly
different from respective value of regular diet ; p<O.05.
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3.2.2. Membr ane potential
The resting £111 of smooth muscle cells of the pulmonary arteries of rats on a high salt diet
was significantly more negative compared to rats on a regular diet (-62.2 ± 1.27 vs -66.9
± 0.96 mY, respectively; Table 7, Figure 16 AC). Addition of isoprenaline (1.0 IlM )
induced significant hyperpol arization of smooth muscle cells of pulmonary arteries of rats
on the regular diet but not of those on the high salt diet (-62.2 ± 1.27 vs -70.6 ± 0.72 mV,
respectively; Table 7; Figure 16 BD, 17B). Exposure to acidic buffer (pH 6.4) resulted in
a significant depolarization of smooth muscle cells of pulmonary arteries of rats on high
salt diet (-68.2 ± 1.01 vs -63.4 ± 1.11 mY, respectively) but not of those on a regular diet
(-6 1.6 ± 1.04 vs -6 1.3 ± 1.24 mY, respectively; Figure 17A). The presence of acidic
buffer significantly impaired hyperpolarization caused by isoprenaline (Table 7; Figure
17B).
L-NAME alone had no influence on the resting £111 of smooth muscle cells in blood
vessels from rats fed either regular (-61.3 ± 0.49 vs -60.4 ± 1.27 mY, respectively) or
high salt diet (-67.9 ± 1.41 vs -67.2 ± 1.36 mY, respectively). In the presence of acidic
buffer, did not produce any additional effects on the resting £111 of smooth muscle cells of
pulmonary arteries from rat fed either diet (Table 7; Figure 17B). Addition of
isoprenaline to acidic buffer containing L-NAME produced similar effects to those of
acidic buffer alone (Table 7). While Ba2+alone did not have an effect, combined with
ouabain it produc ed a significantly greater degree of depolarization in smooth muscle
cells of blood vesse ls from rats on salt compared to those on a regular diet (Figure 17A).
In the presence of Ba2+alone, isoprenaline produced a similar degree of hyperpolarization
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Figure 16. Membrane potential recordings of pulmonary arteries from rat fed regular [R] or 4% salt diet [S] in the presence of
A) regular buffer (control), B) isoprenaline (1.0 IlM), C) regular buffer (control) and, D) isoprenaline (1.0 IlM).
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of smoo th mu scle ce lls of pulmonary arte ries from rats on either high salt (-61 .5 ± 1.84 vs
-65.9 ± 0.45 mY, respectively) or regu lar diet (-57.7 ± 0.38 vs -64 .1 ± 1.56 mY ,
respectively; Tab le 7). In contrast , hyperpolarization evoked by isopre naline was affected
more in the presence of Ba2+ and ouabain in the smoo th muscle ce lls from rats on a high
salt diet (-60 .8 ± 0.46 vs -62.8 ± 0.19 mY , respectively) co mpare d to those on a regular
diet (-58 .7 ± 0.9 7 vs -64 .1 ± 1.15 mY, respect ively; Table 7; Figure 17B).
The extent of the depolari zation by inclu sion of Ba2+ and ouabain in ac idic bu ffer, but not
by BaH alon e in acidic buffer , was significantly different in smoo th muscle cell s of blood
vesse ls from rats on a high salt diet compared to a regular diet (Ta ble 7; Figure 17A).
Isoprenaline was able to produc e a significant hyperpolarization of the smoo th mu scle
cells in acidic bu ffer containing BaH alone in blood vesse ls from rats on a regular die t (-
57.5 ± 0.26 vs -64 .8 ± 0.69 mY , respectively) but not tho se on a high sa lt diet (-60 .6 ±
1.21 vs -62 .8 ± 0.22 mV, respec tive ly; Ta ble 7; Figure 17B). However, in acid ic buffe r,
the combi ned presence of Ba2+ and ouabai n inhi bited isoprenali ne-indu ced
hyperp olarization in blood vesse ls from rats on either regular (-58 .2 ± 0.35 vs -6 1.3 ±
1.55 mY , respectively) or high salt diet (-60.2 ± 1.02 vs -60 .9 ± 1.79 mY , respectively;
Ta ble 7; Figure 17B).
The presence of TEA with Ba2+ and ouabain in regular bu ffer in comp ari son to acidic
buffer produced a similar degree of depolari zation in smoo th mu scle ce lls of pulmon ary
arteries from rats on either diet (Table 7; Figure 17A) . Isoprenalin e-indu ced
hyperpolari zation was between I to 3 mV in tissues with the latter treatment s (Figure
17B).
Table 7. Membrane potential (mY) of smooth muscle cells in main pulmonary artery ring preparations from rats fed regular or
4% salt diets for 18-23 days.
Regular diet 4% Salt diet
Control Treatment Isopr enaline Control Treatment Isoprenaline
No treatment -62.2 ± 1.27 -70.6 ± o.na -66.9 ± 0.96 b -68.3 ± 0.73b
(8)(34) (8)(41) (11)(53) (11)(56)
Acidic buffer -61.6 ± 1.04 -61.3 ± 1.24 -64.2 ± 1.29 -68 .2± 1.01b -6304± i .u- -65 .8±0.97
(5)(24) (5)(24) (5)(21) (5)(22) (5)(22) (5)(21)
L-NAME -61.3 ± Oo49 -6004± 1.27 -66.7 ± 0.68a,< -67.9 ± 1.41b -67.2 ± 1.36 -68.9 ± 0.82
(7)(25) (7)(32) (7)(37) (6)(24) (6)(27) (6)(29)
Acidic buffer + -61.9 ± 1.19 -61.1 ± 1.27 -64.2 ± 1.05 -67.8 ± 1.91b -62.9 ± 0.80a -6504± 1.17
L-NAME (7)(21) (7)(32) (7)(34) (6)(19) (6)(21) (6)(20)
BaCh -60.7 ± 1.21 -57.7 ± 0.38 a -64.1 ± 1.56a,< -66.8 ± 0.66 b -61.5 ± 1.84a -65.9 ± 0045<
(4)(23) (4)(18) (4)(25) (4)(24) (4)(24) (4)(24)
BaCh + Ouabain -61.2 ±Oo48 -58.7 ± 0.97a -64.1 ± 1.15a,< -67.6 ± 0.50 b -60.8 ± 0046a -62 .8 ± 0.19 a
(4)(22) (4)(22 ) (4)(20) (4)(24) (4)(24) (4)(15)
Acidic buffer + BaCh -61.5 ± 0.78 -57.5 ± 0.26a -64.8 ± 0.69a,< -67.2 ± 0.70b -60.6 ± 1.21a -62 .8 ± 0.22a
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(4)(23) (4)(23) (4)(18) (4)(24) (4)(24) (4)(21)
Acidic buffer + BaCh -62.2 ± 0.21 -58.2 ± 0.353 -61.3 ± 1.55 -66.9 ± 1.05b -60.2 ± 1.023 -60.9 ± 1.793
+ Ouabain (4)(22) (4)(21) (4)(22) (4)(23) (4)(23) (4)(17)
BaCh + Ouabain -60.8 ± 1.37 -55.9 ±0.863 ,d -57.7±0.81 -66.6 ± 0.06b -57.9 ± 0.503 ,e -58.9 ± 1.793
+ TEA (4)(16) (4)(26) (4)(24) (4)(16) (4)(23) (4)(13)
Acidic buffer + BaCh -61.3 ± 1.01 -56.4 ±0.543,d -58.3 ± 0.623 -68.6 ± 0.83b -57.2 ± 1.203 ,e -58.6 ± 0.703
+ Ouabain + TEA (4)(15) (4)(21) (4)(24) (4)(15) (4)(23) (4)(20)
Acidic buffer (pH 6.4 ± 0.2); N'" nitro-L-arginine -methyl ester (L-NAME; 10 11M);BaCh (100 11M); Ouabain (100 11M);
Tetraethylammonium (TEA; 3.0 mM)
Each value is the mean ± s.e.m., with the number of rats and of cells indicated in parentheses .
"Significantly different from respective control; p<O.05
"Significantly different from respective control (regular diet);p <0.05
"Significantly different from respective treatment ; p <O.05
dSignificantly different from acidic buffer (regular diet); p<O.05
"Significantly different from acidic buffer (salt diet); p<O.05
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Figure 17. Effect of regular buffer (RB) and acidic buffer (A; pH 6.4) in abse nce and presence of various pharmacological
agents on A) membrane potential (Em)and B) isoprenaline elicited hyperpolarization in vascular muscle of main pulmonary
arteries from rats on a regular or a high salt diet. N'" nitro-L-a rginine methyl ester; (L-NAME ; 10 11M), Ba2+;(Ba; 100 11M),
Ouabain ;(O; 100 11M), TEA (T; 3 mM). Resting Em: regular diet: 61 .5 ± 0.32 mV (mean ± s.e.m., n=51 rats & 221 cells) ; high
salt diet : 67.4 ± 0.36 mV (mean ± s.e.m., n=52 rats & 244 cells) . ' Significantly different from respective value of regular diet ;
p <O.05. #Significantly different from respective treatment ;p<O.05.
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3.3. Study 111.Effect of denudation of endothelium on vascular p-adr enoc eptor
signalling in rats fed a high salt diet
3.3. 1. Mechanica l Function
3.3.1.1. Intact tissues
Isoprenaline-induced responses for intact tissues with Emax and pECso in absence or
presence of various treatments were described in section 3.2.1. For purposes of
compar ison, the data for vehicle (ddH20 200 ul.), acidic buffer (pH 6.4), Ba2+,ouabain or
the combination of these interventions is mentioned again in Table 8.
3.3.1.2. Denuded tissues
Relaxant responses to isoprenaline were significantly attenuated in denuded tissues
compared to intact tissues as evidenced by their respective Emax and pECsovalues (66.25
± 1.59% and 7.07 ± 0.03; n = 40 vs 83.79 ± 1.23% and 7.27 ± 0.03; n = 39). The removal
of endothelium significantly reduced isoprenaline mediated maximal responses (Table 8;
Figure 18A). The presence of acidic buffer did not affect inhibition of isoprenaline-
induced vasore laxation (Table 7; Figure 18B). Ba2+alone and in combination with
ouabain in both regular buffer and acidic buffer significa ntly reduced isoprenaline-elicited
relaxations (Table 8; Figure 19A and 19 B, 20A and B). However, inhibition of
isoprenaline-induced relaxations were noticeably less with Ba2+alone and in combination
with ouabain in acidic buffer compared to in regular buffer.
Tab le 8. Percent maximal response (Emax) and pECsodetermined from individual concentration-response curves for isoprenaline
in main pulmonary artery ring preparations with (+E) and without (-E) endothelium from rats fed a 4% salt diet for 18-23 days.
4% Salt diet (+E) 4% Salt diet (-E)
pECso Emax pECso s.:
Control 7.29 ±0.02 79.17±3.48 6.99 ± 0.08 65.86±3.43
Acidic buffer 6.70± 0.19a 43.00 ±3 .53a 6.78 ± 0.09a 66.29 ± 4.73c,e
Control 7.15±0.07 78.17± 2.26 7.06 ± 0.04 63.14 ± 6.05
BaCh 6.98± 0.05 48.50 ± 3.03a 6.68 ± 0.09a 28.29 ± 3.42a,c
Control 7.18 ±0.11 85.67 ± 1.14 7.02 ± 0.07 65.83 ± 5.33
Acidic buffer + BaCh 6.52 ± 0.06a 47.33 ± 2.73a 6.64 ± 0.16 39.17 ± 5.53a,c
Control 7.30 ± 0.05 87.88 ±2.05 7.05 ±0.05 64.71 ± 1.66
BaClz + ouabain 6.83 ± 0.14a 27.88 ± 3.62a,b,d 6.81 ±0.07a 17.57 ± 2.54a,c
Control 7.25 ± 0.07 81.67 ± 3.58 7.09 ± 0.04 69.17 ± 2.04
Acidic buffer + BaCh + ouabain 6.46 ±0.13a 37.83 ± 2.83a,b,d 6.47 ± 0.09a 33.00 ± 6.32a,c
Acidic Buffer (pH 6.4) BaCh (100 JlM); ouabain (100 JlM)
Each value is the mean ± s.e.m., n= 6-8
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'Significantly different from respective control;p <O.05
"Significantly different from acidic buffer (+E); p <O.05
"Significantly different from acidic buffer (-E);p <O.05
dSignificantly different from BaCb (+E);p <O.05
'Significantly different from BaCb (-E);p <O.05
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Figure 18. Concentration-response curve for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal
contractions) in intact {+E} and denuded {-E} main pulmonary artery ring preparations from rats fed a high salt diet [S] in A)
regular buffer (control) and twice-distilled water and; B) regular buffer (control) and acidic buffer. Each point represents a mean
± s.e.m. of seven experiments .
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Figure 19. Concentration-response curve for isoprenaline (% relaxation remaining from phenylephrin e induced sub-maximal
contractions) in intact {+E} and denuded {-E} main pulmonary artery ring preparations from rats fed a high salt diet [S] in A)
regular buffer absence (control) or presence of BaCh and; B) regular buffer (control) or acidic buffer plus BaCh . Each point
represents a mean ± s.e.m. of six to eight experiments.
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Figure 20. Concentration-response curve for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal
contractions) in intact {+E} and denuded {-E} main pulmonary artery ring preparations from rats fed a high salt diet [S] in A)
regular buffer absence (control) or presence of BaCb and ouabain together and; B) regular buffer (control) or acidic buffer plus
BaCb and ouabain together. Each point represents a mean ± s.e.m. of six to eight experiment s.
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Table 9. Membrane potential (mV) of smooth muscle cells in main pulmonary artery ring preparations with (+E) and without (-
E) endothelium from rats fed a 4% salt diet for 18-23 days.
4% Salt diet (+E) 4% Salt diet (-E)
Control Treatment Isoprenaline Control Treatment Isoprenaline
No treatment -66.9 ± 0.96 -68.3 ± 0.73 -69.6± 0.98 -69.7±2.17
(11)(53) (11)(56) (5)(16) (5)(11)
Acidic buffer -68.2± 1.01 -63.4 ± 1.11" -65.8 ± 0.97 -69.2 ±0.65 -66.3 ± 2.88 -66.7± 2.88
(5)(22) (5)(22) (5)(21) (5)(20) (5)(17) (5)(12)
BaCh -66.8 ± 0.66 -61.5 ± 1.843 -65.9 ± 0.45b -69.5 ± 1.28 -59.9± 1.413,d -61.1 ± 1.233
(4)(24) (4)(24) (4)(24) (4)(15) (4)(19) (4)(12)
Acidic buffer + BaCh -67.2 ± 0.70 -60.6 ± 1.213 -62.8 ± 0.223 -68.2 ± 1.07 -57.9 ± 1.463,d -60.5 ± 1.293
(4)(24) (4)(24) (4)(21) (4)(15) (4)(18) (4)(15)
BaCh + ouabain -67.6 ± 0.50 -60.8 ± 0.463 -64.7 ± 1.I2 3 ,b -69.4± 1.38 -58.1 ± 1.I3",d -60.3 ± 1.953
(4)(24) (4)(24) (4)(19) (4)(17) (4)(22) (4)(13)
Acidic buffer + BaCh -66.9 ± 1.05 -60.2 ± 1.023 ,< -60.1 ± 2.403 -68.4 ± 1.15 -59.9± 1.733,d -61.8 ± 1.553
+ ouabain (4)(23) (4)(23) (4)(18) (4)(15) (4)(19) (4)(13)
Acidic Buffer (pH 6.4 ± 0.2); BaCh (100 11M);ouabain (100 11M)
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Each value is the mean ± SE. with the numb er of rats (= n) and number of cells indic ated in parentheses.
'Si gnificantly different from respective contr ol; p<O.05
bSignificantly different from respective treatment ; p<O.05
<Significantly different from acidic buffer (+E); p<O.05
dSignificantl y different from acidic buffer (-E); p<0.05
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3.3.2. Membrane potential
3.3.2.1. Intact tissues
The £11I for intact tissues was stated in section 3.2.2. For evaluation purposes , the data for
no treatment, acidic buffer (pH 6.4), Ba2+, ouabain or combination of these interventions
is mentioned again in Table 9.
3.3.2.2. Denuded tissue
Hyperpolarization recorded in smooth muscle cells was of similar magnitude in
pulmonary arteries with (-66.9 ± 0.96 vs -68.3 ± 0.73 mY, respectively) or without
endothelium (-69.6± 0.98 vs -69.7± 2.17 mY, respectively) from rats fed a high salt diet
(Table 9). The presence of acidic buffer did not affect resting £11I of smooth muscle cells
(-69.2 ± 0.65 vs -66.3 ± 2.88 mY, respectively; Table 9). BaH (-69.5 ± 1.28 vs -59.9 ±
1.41 mY, respectively) alone and together with ouabain in absence (-69.4 ± 1.38 vs -58.1
± 1.13 mY, respectively) and presence of acidic buffer(-68.4 ± 1.15 vs -59.9 ± 1.73 mY,
respectively) significantly depolarized vascular smooth muscle cells compared to acidic
buffer alone (Table 9). The extent of isoprenaline-indu ced hyperpolarization was
noticeably reduced in the absence or presence of various treatments such as acidic buffer
(pH 6.4), Ba2+, ouabain or combination of these interventions.
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4.0. DISCUSSION
Removal endothelium produced hyperpolarization of vascular smoo th muscle cells in
blood vesse ls obtained from rats fed regular diet. The hyperpolarisation due to
denud ation was the result of the activation of K+channels and Na+/K+ATPase . p-
adrenoceptor-evoked hyperpolarization appeared to be mutu ally dependent on the
presence of endothelial cells. Isopr enaline-induced hyperpolarization was absent in
denuded tissues. p-adr enoc eptor-mediated relaxation was found to be partly dependent
on the presence of endothelium. Isoprenaline produced similar relaxation s in intact
pulmonary arteries obtained from animals fed a high salt compar ed to normal diet.
However , the EII/was found to be hyperpolari zed in intact pulmon ary arteries of animals
fed a high salt diet comp ared to those fed a normal diet. The isoprenaline evoked
hyperpolarization was notably absent in the pulmonary arte ries. In addition, in intact
versus denud ed blood vessels obtained from rats on high salt diet Emwas not significa ntly
different. Collective ly, the studies concluded that the presence of the endothelium is
essential for the propagation of p-adrenoceptor-m ediated relaxation. Moreover, the
evidence see m to also imply that consumption of high salt leads to the activation of K+
channels and Na+/K+ATPase channels preserving p-adrenoc eptor -mediated relaxations in
pulmonar y arterie s.
A substantial amount of evidence suggests that a link betwe en excessive consumpti on of
Na+ in the form of diet ary salt and deve lopment of hypertension (lnters alt , 1988). This
observation stand s true for both human and animal popul ations (Tobian, 1991; Meneton
et al., 2005; He and MacGr egor, 20 10). In animal s, this is particularl y marked in the
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genetically selected Dahl salt sensitive rats (Dahl et al., 1962), but it also occurs to a
smaller extent in non-selected animals including Sprague-Dawley rats (Sofola el al.,
2002), Wistar rats (Huang & Johns, 2000) , and chimpanzees (Denton et al., 1995).
In the latter mentioned animal population, high salt consumption has been linked with
causing adverse cardiovascular effects (i.e. ventricular or vascular hypertrophy) without
altering the blood pressure (Tobian, 1991; Menton et al., 2005; He and MacGregor,
2010). The mechani sms linking consumption of high salt diet and hypertension! adverse
cardiovasc ular effects appears to be complex and to involve alteration in the
cardiovascular system i.e. heart, kidney and vascular system (Tobian, 1991; Menton et
al., 2005; He and MacGregor, 2010).
The alteration of adrenergic responsiveness due to the consumption of high salt diet could
be an important factor in the pathogenesis and maintenance of the hypertension and thus
cardiovascular disease (Feldman, 1990 a; Michel et al., 1990; Brodde and Michel, 1992).
One of the possible mechanisms that is a contributor to the increased in peripheral
vascular resistance is an increase in n-adrenoceptor mediated vasoco nstriction (Michel et
al., 1990; Brodde and Michel, 1992). However, an alteration in other vascular
adrenoceptors i.e. p-adrenoceptor responsiveness could also be a contributing factor to the
overall increase in peripheral resistance in the hypertension. Blunted p-adrenoceptor
responses have been reported in hypertensive animals and humans (Field and Soltis,
1985; Naslund el al., 1988; Feldman, 1990b; Borkowski et al., 1992). Further, high salt
diet has inconsistent effects on p-adrenoceptor-mediated vasore laxation. In humans, a
reduction in salt intake has been associated with improved p-adrenoceptor-mediated
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vaso dilation (Nas lund et al., 1988 ; Feldman, I990 b) and imp roved vasc ular distensibility
in hypertensive and elderly patient s (Avo lio et al., 1986; Gates et al., 200 4). In Dah l-salt
sensit ive rats fed a high salt diet, p-adrenoceptor-mediated responses to iso prena line were
attenuated in ao rtic ring (So ltis and Katovich, 1991) but were unchanged in pulm onary
arteries (Fo rd et al., 20 11). Thi s discrepanc y could be associa ted with vari abilit y in the
vascul ar beds (i.e. sys temic vs pulm onar y) and di fferent intracellular signa lling path way
activated as a con sequen ce of p-adrenoc eptor stimulation i.e. cAMP, PKA, cGMP and
pota ssium channels (Scheid et al., 1979; Ruban yi and Vanhoutt e, 1985 ; Nakashim a and
Vanhoutte, 1995 ; Bieger et al., 2006). Against this back ground , the current thesis
research was undert aken to assess the electric al and mech anic al diff erences in the low
pressure segment of the circul atory system (pulmonary arte ry) from Spra gue-D awley rats
on regular and high sa lt diet.
4.1. Role of endothelium in p-adrenoceptor signalling
p-adrenoceptor-mediated responses in the rat pulm onary arte ry have both endot helia l
dependent and indep end ent comp onents. In an intact tissue, p-adrenoceptor stimulation
produc es hyperp olari zation of smoo th muscle cell s via the activation of an ac id-se nsitive
channel (i.e. TASK ). This latter response was abse nt in the endo the lial denuded tissues.
Bieger et ai, (2006) demon strat ed that isopr enaline-evoked hyperpolarization in the
isolat ed rat main pulmonary arter y was not onl y sensitive to inhibitory actions of acidic
buffer but also to the anandamide (TAS K chann el antagonist). Anandamide also
produ ced conc entr ation dependent inhibition of the relaxation and inhibiti on of
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hyperpolarization elicited by isopr enaline (Biege r et al., 2006) . TAS K channels are
prese nt in rat pulm onary artery (Gardener et al., 2004) and were found to be sens itive to
inhibiti on by anandamide (Ma ingret et al., 200 I ; Gurney et al., 2003). In the present
study, hyperpolari zat ion induced by stimulation ofp-adre noce ptors was sig nifican tly
inhibit ed by the pre senc e of ac idic buf fer but not Ba2+, ouabain or TEA alone. The latter
sugges ts that TA SK pla ys an integral role in p-adrenoceptor-mediated hyperpolari zation .
In the pulmonary arte ry, Ba2+and ouabain together inhibited p-adr enoceptor-m ediated
mech anical respon se in the absence and presen ce of endothe lium. Ba2+and ouabain
together mod estly inhibited isopren aline-evoked hyperpo larization in intact arterie s
compared to denuded arteries. Moreo ver, acidic buffer combined with Ba2+and ouabain ,
did not cause furth er inhibition of the relaxation when comp ared to Ba2+ and ouabain
combin ed. In accord ance to the menti oned observation , it is plausibl e to suggest that the
stimulation of Bvadrencceptcr caused the acti vation of TA SK chann els, likely located on
the smoo th muscle cell s, leadin g to modest efflux of K+ which then perpetu ated the
opening Kir2.1channels and/o r the ove r-activation of Na+/K+ATPase leadin g to a we ll
defin ed susta ined hyperp olarization of approx imately 8.0 mY in an intact blood vessel.
Alternative ly, it is also be possibl e that TASK, Kir2.1, Na+/K+ATPase were activated in
parall el and work ed in concert to produce the isoprenaline mediated hyperp olarization .
Evidently , isopre naline mediated vasorelaxa nt respon ses were simi lar in the presen ce of
acidic buffer and Ba2+sugg esting that the latter mig ht be acti ng as an inhibitor of TASK
channe ls in addition to its ef fect on Kir2.1. Nonetheless, Ba2+ is belie ved to be a relativ ely
selective inhibitor of Kir2.1channels (Sabirov et al., 1997; Owen et al., 1999).
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Figure 21. A schematic demonstrating p-adrenoceptor (P-AR) signa lling in intact rat main pulm onary artery .
Inward rectifier potassi um channels , (K ir2.1) ; electroge nic pump, (Na+/K+ATPase) ; endothelia l cell, (EC); vascular smooth
muscle cell, (YSMC) ; two-pore domain acid sensit ive K+channels , (TASK) .
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Yet, another hypothesis cou ld be that stim ulation of p-adrenoceptors resulted in
endothe lium dependent hyperpolarization. This event would have had to predominantly
occur via the activation of acid-sensitive channels, and a portion of the electrical respo nse
may have been brou ght on as a result of the so called "potassium clouds" i.e. activation of
Na+/K+ATPase causing the Kir2.1channels to open (Edwa rds and Weston, 2004) .
Hyperp olarization of vascular smooth muscle cells is believed to occur under certain
cond itions due to K+efflux via Kir2.l and/or Na+/K+ATPase as a consequence of the
activation of the interm ediate Ca2+-activated K+channels located on the endothelial cells
(F616touand Vanhoutte , 2009). However , this does not explain the findin g that the
acidification of the buffer and anandamid e were both capable of inhibitin g
hyperpolarization and relaxati on induced by isoprenalin e in such blood vessels (Bieger et
al., 2006) . As well, in the present investigation , a comb ination of BaH and ouabain
inhibited isoprenal ine-indu ced relaxation in both intact and denud ed tissue to a similar
degree.
It was also observed that TEA partially attenuated hyperpolarization induced by
isoprenaline in intact pulm onary arteries. TEA caused a modest but not significant
inhibiti on of the relaxation in the intact tissues. The lack of complete inhibition of
hyperpolari zation by TEA in the presence of isopren aline may support the view that the
latter intervention unlik e acidic buffer is not able to substantially inhibit the K+channels
that are activated by the stimulation of p-adreno ceptors in isolated rat pulmon ary arteries.
In the rat abdominal aorta, p-adrenoceptor-m ediated relaxation has been reported to be, in
part, dependent on the activation of large-conduct ance, Ca2+-sensitive K+channels (BK)
K +efflux? hyperpolarizationi
Figure 22. A schematic demonstrating denudation-induced hyperpolarization in rat main pulmonary artery .
Inward rectifier potassium channels, (Kir2.1);electrogenic pump , (Na+/K+ATPase); vascular smooth muscle cell, (VSMC) ; two-
pore domain acid sensitive K+channels , (TASK)
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(Matsushita et al., 2006) while in the isolated rat aorta , relaxant respo nses to isopre naline
were partly inhibit ed by TEA (Kang et al., 2007). It had been previously reported that
charybdotoxin but not apamin also partially attenuated relaxant responses to isoprenaline
in intact rat main pulm onar y artery (Bieger et al., 2006) . Furthermore , relaxant responses
to isoprenaline in rat pulm onary artery could be completely abolished by elevation in the
extrace llular concentration of K+ (30 mM) (Bieger et al., 2006). Co llective ly, the
evidence seems to suggest that the relaxant responses due to the stimulation of~­
adrenocep tors in vascula ture are partly dependent upon the activatio n ofK+ channe ls.
It is eviden t that denud ation can abolish hyperpolarization caused by isopre naline in rat
main pulmonary artery. We did observe that the removal of the endothelial cells resulted
in the Emshifting to a more negative setting of approx imately -67 mV. One simple
explanation could be that the substantial hyperpolarization follow ing denud ation rendered
the TAS K channels inefficient to cause further hyperpolarization upon stimulation of~­
adrenoce ptor . The EK in single vasc ular muscle cell has been repor ted to be about -75
mV (Russe ll et al., 1992). It is possible, that since denud ation of blood vesse ls caused an
increase in Em(i.e. hyperpol arization) of the smooth muscle cells, this subdued the
participation of the acid-sensitive channels following the application of isoprenaline as Em
was brought close to EK(Figure 22).
Altoget her, the study sugges ts that the denudation of blood vesse ls causes
hyperpolarization of smoo th muscle cells as a result of the activa tion of Kjr2.Jand
Na+/K+ATPase . Moreover, inclusio n of BaH and ouabain in acidic buffer does not
produce any additive depolarization of denud ed pulm onary arteries . It is also apparent
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that this hyperpolarization is brought on in part via the activation of K + channels, since
TEA was able to produc e modest depolarization in denud ed tissues without having any
impact in the intact blood vesse ls. Therefore, it is reasonable to assume that the
participation of Na+/K+ATPaseand K + channels includin g the K ir2.1 in increasing the Em
meant that the electrica l responses caused by the stimulation of p-adrenoceptors seem no
longer a viable trigger in generating hyperpolarization in a denud ed blood vesse l.
4.2. Influence of high salt diet on p-adrenoceptor signalling .
In the current inves tigation, hyperpolarization observed in vasc ular muscle of blood
vesse ls from animals on a high salt diet is in accord with previous work from this
laboratory (S ieger et al., 2004; Parai and Tabrizchi, 2005) . An approx imate ly 6.0 mV of
hyperpolarization was record ed in the resting Emof smooth muscle cells of the main
pulmonary arteries of rats that consumed a high salt diet in compar ison to a regular diet.
This hyperpolarization can be attributed to the opening of K + channels and the activatio n
of Na+/K+-AT Pase. It is also apparent that isoprenaline-induced relaxa tions were not
perturbed in pulm onar y arter ies from rats fed a high salt diet compared to those on a
regular diet. The latter observa tion could be taken to indicate that hyperpolarization of
smooth muscle cells of the pulmonary arterial vesse ls played a pivota l role in preserving
isoprenaline-media ted relaxations in tissues obtained from animals on a high salt diet.
Support for this view stems from a recently publi shed report by Garland and colleagues
(20 II ). These investigators have purposed the view that hyperpolarization of smoot h
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muscle cells evoked by the stimulation of p-adrenoceptors is instrumental in spreading of
vasodilation in blood vessels (Garland et al., 2011). Therefore , hyperpolarization may be
a compensatory mechanism to restore the normal relaxant responses to p-adrenoceptor
stimulation in tissues from animals that consumed a high salt diet.
A modest but significant increase in blood pressure was recorded in normotensive rats
after consumpti on of high salt diet in our present study. Similarly, Sofola et al. (2002)
also reported a significant increase in blood pressure of Sprague-Dawley rats fed a high
salt diet compar ed to those on a regular diet. In systemic arteries, an increase in blood
pressure has been reported to attenuate p-adrenoceptor-mediated functional and
membrane potentials (Asano et al., 1982; Borkowski et al., 1992; Goto et al., 2001).
Previously evidence from this laboratory indicated that salt-induced systemic
hypertension in Dahl rats did not lead to elevation in pulmonary arterial pressure (Bieger
et al., 2004). However, it was noted that alteration in receptor-mediated signal
transduction evolved in pulmonary arterial vascular bed of Dahl hypertensive rats fed a
high salt diet independent of elevation in systemic arterial pressure (Bieger et al., 2004).
It was observed that the electrolyte levels were similar in plasma collected from the
animals fed either regular or high salt diets. Even though we did not detect any
significant changes in plasma levels of'Na" in animals fed a high salt diet, it is plausible
that alteration in p-adrenoceptor-mediated signal transduction noted in our present
investigation may have occurred as a consequence of small daily fluctuations in plasma
levels ofNa+due to the consumpti on of high salt diet. Data in the literature supports the
view that a rise in Na+concentration greater than 2 mmol/L induces changes in vascular
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response independent of the increase in blood pressure (de Wardener et al., 2004). This
may have been the case in the current investigation.
Dietary salt intake has also been shown to have a variable influence on p-adrenoceptor-
mediated vascular responses. An intake of high salt in the diet has been implicated as a
cause for an impaired p-adrenoceptor-mediated response (Feldman, 1990 a). For
instance, in borderline hypertensive patients or elderly normotensive individuals, a
reduction in salt intake results in normalized p-adrenoceptor-mediated venodilation
(Feldman, 1990 b, 1992). However, Naslund and colleagues (1990), in forearm brachial
artery, have found that the potency of isoprenaline-induced vasodilation increased in salt
insensitive individuals after six days on high salt diet (250 mmol Na+ per day) compared
to individuals on a low salt diet (10 mmol Na per day). Experimental evidence for the
influence of high salt diet on vascular p-adrenoceptor-mediated responses varies in rat.
For example, Soltis and Katovich (1991) demonstrated that isoprenaline evoked relaxant
responses were attenuated in aortic rings from of Dahl-salt sensitive rats following three
weeks on high salt diet. In contrast, isoprenaline mediated relaxant responses were not
different in pulmonary artery from Dahl-salt sensitive rat fed a high salt diet (Ford et al.,
20 11). This noted variance between the former and latter findings as to the effect of high
salt diet on p-adrenoceptor-mediated relaxations could be due to differences in the nature
of the vesse ls i.e. systemic arteries that cater high blood pressure as compare to
marginally lower pressure by pulmonary arteries.
Here, it is also evident that isoprenaline-induced hyperpolarization in tissues from rats on
the high salt diet was absent. Based on the electrophysiologica l data in our current study,
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the hyperpolarization recorded in vascular smooth muscle cells of pulmonary arterial
vesse ls from rats fed a high salt diet compared to regular diet is mainly due to the
activation of the leak K+current, opening of the Kir2.1channels, the activation of
Na+IK+ATPase and to a modest degree the opening of the TEA -se nsitive voltage-gated
K+channels. Thu s, it is plausible that since consumption of the high salt diet had alread y
caused the opening of K+ channels and activation ofNa+/K+ATPase, leadin g to the
hyperpolari zation of vascular muscle cells, isoprenaline was no longer capable of
producin g a furth er decrease in the Em. Alternati vely , it is possible that Emof smoo th
muscle cell s of the pulm onar y arterial vessels of rats fed a high salt diet was close to the
K+reversal potential and further hyperpol arizat ion by isoprenaline did not ensue. As
mentioned earlier, Ek of single smooth muscl e cell has been reported to be approx imately
-75 mV (Russe ll et al., 1992)
Stimulatio n of p-adrenoceptors in vascular muscle leads to the activations of the adenylyl
cyclase with a subseq uent increase in intrace llular cAM P concentration and
vasore laxa tion (Scheid et al., 1979). In rat pulm onary arte ry, TAS K channels have been
reported to be present in vasc ular muscle (Gardener et al., 2004) . In addition, it seems
that the activation of these acid-se nsitive leak channels can occur independently of
adenylyl cyciase/cAMP /PKA pathway (S ieger et al ., 2006) . This study seem to also
reveal that cAMP antagoni st, Rp-cAMP , did not display any differential inhibit ory
response on isoprenaline-mediated relaxation s in tissues from animal s fed a high salt diet
versus those on a regular diet. This would argue aga inst a modified role for cAMP in
tissues from animals on high salt compared to a regular diet.
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The p-adrenocep tor-media ted relaxation in part is mediated via eNOS/NO/cGMP
pathway (Priest et al., 1999; Bieger et al., 2006) . In the current investigat ion, the latter
pathway does not seem to play any role in p-adrenoceptor-mediated hyperpolarization.
However, previo us ev idence from our laboratory demonstrated that consump tion of high
salt resulted in hyperpolar ization of mesenteric artery of Dahl salt- resistant rats. This
hyperpol arization was reversed by L-NAM E (Parai and Tabr izchi , 2005) . In contrast,
isopren aline-induced relaxation of the pulmon ary artery of Dahl salt-sensitive rats (Ford
et al., 2011) was found to be insensitive to inhibition by L-NAM E. In our present study,
hyperpolari zat ion of vascular smooth cell brought on by consumption of the high salt diet
was found to be insensitive to the action of L-NAM E. Taken together, our current
observa tions suggest that an altered role for eNOS/NO/cGMP pathway in relation to
isoprenaline-induced hyperpolarization and relaxation in pulmonary arterial vessels from
rats fed a high salt seems tenuous.
Interestingly, the opening of Kir2.1(BaH-sensitive) and the activa tion ofNa+/K+ATPase
(ouabain-sensitive) appear to be an integral part of the resting Emin the pulm onary
arterial vesse ls from animals fed a high salt diet. The assoc iation between the opening of
Kir2.1and activation of Na+/K+ATPase (via potassium cloud) and the ensuing
hyperpol arization of vasc ular smooth muscle in an intact blood vesse l is well docum ented
in the literature (Edward s et al., 1998; Weston et al., 2002). It is also clear that Ba2+
together with ouabain but not alone produced a much greater inhibitory effect of
isoprenaline evoked relaxati ons in tissues from rats fed a high salt diet comp ared to those
on a regular diet. Moreover, inhibition of TA SK channels by acidic buffer also produced
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a grea ter inhibition of relaxation caused by isoprenaline in pulm onary arterial vessels
from rat on a high salt diet compared to a regular diet. Taken together, such evide nce
could imply that TAS K and the combined effects of Kir2.1and Na+/K+ATPase act in
parallel in manifestation of the hyperpolarization due to the activation of' [f-adrenocep tors
by isoprenaline. Furthermore, it is also possible that opening of TAS K might act as
trigger for the activation of potassium cloud to preserve ~-adrenoceptor mediated
relaxations in blood vessels from animals on the high salt diet. However, based on our
current electrophysiolog ical and mechanical data, it is also clear that a limited, if any,
modifi cation of the role for TEA -sensitive channels has occurred in associa tion with ~­
adrenoce ptor-mediated response in tissues from rats fed a high salt diet. This is in
contrast to the changes observed for the role of TAS K and Kir2.1channels and
Na+/K+ATPase on both mechanical and electrical functions due to the stimulation of ~­
adrenocep tors in blood vesse ls from rats on a high salt in comparison to regular diet.
In conclusion, vascular ~-adrenoceptor signalling has clearly multipl e electrical
components in rat main pulmonary arteria l vessels . The sustained hyperpolarization
observed with chronic consumpti on of high salt diet involves the opening of leak
channels (TAS K) and Kir2.1channels and the activation of Na+/K+ATPase. This
hyperpolar ization preserves isoprenaline evoked relaxant responses in the main
pulmonary arter y. The vasodilatory responses to isoprenaline were not significantly
changed in rats fed a high salt diet. However, they appeared to be mediated mainly by K+
channels and Na+/K+ATPase rather than by NO as in the regular diet animals.
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4.3. Effect of denudation of endothelium on vascular p-adrenoceptor signalling in
rat s fed a high salt diet.
The remova l of endothelium resulted in hyperpolarization of similar magnitude in smooth
muscle cells of pulm onary artery from rats fed a high salt diet compared to endothelium
intact tissues from rats fed the same diet. Ba2+ but not acidic buffer depolarized the
smoo th muscle cells from denud ed pulmonary artery from rats fed a high salt diet. The
Emof smoo th muscle cell s, following denud ation of pulmonary artery of rats on either
regular or high salt diet was also compara ble (Table 3 and 9). In agree men t with previo us
findings, isoprenaline did not further hyperpolarize the smooth muscle cells with EIII
ranging from -67 mV to -70 mV (Table 3, 7 and 9). Isoprenaline-indu ced maxima l
response was attenuated in denud ed tissues comp ared to intact tissues in rats fed a high
salt diet. The res idual isoprenaline-mediated relaxation was not mediated by TASK
channels but by Bi +sensitive Kjr2.1channels.
Replott ing figures from previously mentioned data sugges ts that the extent of inhibition
of maximal response was similar in denuded tissues from rats fed either a regular or high
salt diet (Figure 23A). Despite producing significa ntly greate r inhibition in intact
pulmonary arteries from rats on a high salt diet, the inhibitory effec ts of acidic buffer
were dim inished in denud ed pulm onary arteries from rats fed a regular or a high salt diet
(Figure 23B). We found that, L-NA ME produced simi lar inhibition of isopre naline-
mediated relaxant responses in tissues from rats fed a regular compared to high salt diet.
The presence of L-NAM E in acidic buffer produced additive inhibition that was greater in
pulmonary arteries from rats on a high salt diet compared to a regular diet. This additive
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effect observed in tissues from rats fed a high salt diet could be attributed to inhibition of
TASK channel s. Hyperpolarization recorded in the endothelium intact pulmonary artery
of rats fed a high salt diet was sensitive to acidic buffer. Interestingly, in the absence of
endothelium, smooth muscle cells were hyperpolarized and this event was sensitive to
BaH but not to acidic buffer in rats fed a high salt diet. Considering this evidence, it
would be fair to argue that the presence of endothelium is necessary for the TASK-
mediated mechani cal and electrical responses in pulmonary artery of rats on either regular
or high salt diet.
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Figu re 23. For discussion purposes the following figures are replotted from previously mentioned data. Concentration -response
curves for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal contractions) in intact {+E} and
denuded {-E} main pulmonary artery ring preparations from rats fed a regular [R] and high salt diet [S] in A) regular buffer
(control) and twice-distilled water and; B) regular buffer (control) and acidic buffer. Each point represents a mean ± s.e.m . of six
to seven experiments.
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A major component of p-adrenoceptor signalling is BaH sensitive alone and mutually
with ouabain. It was observe d that the high salt diet played a role in the over -stimulation
of Ba2+ sensitive component of isoprenaline signalling. In study I, removal of the
endothelium attenuated the Ba2+-mediated inhibit ion of isoprenaline relaxan t responses .
As previo usly mentioned, it is possible that Ba2+ might also inhibit TAS K channels
involved in p-adrenoceptor signalling. Inhib ition produced by acidic buffer and BaH was
comparable in intact and denud ed pulm onary artery from rats fed a regular diet. In study
II , reducti on of maxim al responses to isoprenaline by BaH was of similar magnitude in
intact blood vessels from rats fed a regular or high salt diet. It is also evident that the
degree of inhibit ion of isoprenalin e-indu ced relaxant responses with BaH was greater
accentuated in denud ed pulm onary arter ies from rats fed a high salt diet compared to
tissue from rats fed the regular diet (Figure 24A). The presence of Ba2+ in acid ic buffer
also resulted in an additive effect in intact blood vesse ls from rats a fed high salt diet, and
in endothelium denud ed tissues from rats on either, high salt diet or regular diet (Figure
I3B and 24B). It is evident that high salt diet has increased the participation of Ba2+
sensitive Kir2.1channels in p-adrenoceptor-mediated relaxation in the pulm onary artery
(Figure 13AB. and 24 AB). These findin g also seem to support the view that TASK
channels are insensiti ve to the inhibitory action of BaH (Lesage and Lazdunsk i, 2000) .
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Figure 24. For discussion purposes the following figures are replotted from previously mentioned data. Concentration-response
curves for isoprenaline (% relaxation remaining from phenylephrine induced sub-maximal contractions) in intact {+E} and
denuded {-E} main pulmonary artery ring preparations from rats fed a regular [R] and high salt diet [S] in A) regular buffer
absence (control) or presence of BaCh and; B) regular buffer (control) or acidic buffer plus BaCh. Each point represents a mean
± s.e.m. of six to eight experiments .
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It is consistent with study I and II that the "potass ium cloud s" theory could play an
important role in vasc ular smoo th muscle relaxation and hyperpolarization (Edwar d et al.,
1998; Weston et al., 2002) . The latter process may play a modest role in p-adrenoceptor
mediated responses in endothelium intact pulm onary arteries of Sprag ue Dawley rats fed
a regular diet. However , it is evident that the contribut ion of the Kir2.1and Na+/K+ATPase
sign ificantly increased in the pulm onary arter ies from rats fed a high salt diet compared to
rats fed a regular diet. Furthermo re, no difference was observe d in the degree of
attenuation of isoprenaline mediated responses in pulmonary artery with or without
endothelium from rats fed either a regular or high salt diet (Figure 25A). It is also evident
that addition of ouabain and BaH combined in acidic buffer resulted in inhibition of a
similar magnitude in tissues with or without endothelium from rats fed a high salt diet
(Figure 24B). Accordingly, this could sugges ts that remova l of endothelium leads to
over-activation of Kir2.1further causing hyperpolarization of smoo th muscle cells from
pulmonary arteries of rats fed a high salt diet.
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Figure 25. For discu ssion purposes the following figures are replotted from previously mentioned data. Concentration-response
curve s for isoprenaline (% relaxation remain ing from phen ylephrine induced sub-max imal contractions) in intact {+E} and
denuded {-E} main pulmonary artery ring preparations from rats fed a regular diet [R] in A) regular buffer absence (control) or
presence of BaCh and ouabain together and; B) regular buffer (control) or acidic buffer plus BaChand ouabain together. Each
point repre sents a mean ± s.e.m. of six to eight experim ents .
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4.4. Conclusion
The stimulation of'Bvadrenoceptors causes hyperpol arization of vascular smooth muscle
cells . Isoprenaline-induced hyperpol arization in part contributes to the p-adren oceptor
mediated relaxation of the rat main pulmonary artery. The vascular p-adrenoc eptor
mediated signal transduction consi sts of multiple compon ents with a sequence of events
that include the activation ofK+channels (TASK and Kir2.1) and Na+/K+ATPase. The
evidence implies that in the presence of endothelium, the hyperpolarization of vascular
smooth muscle cells via the activation of Kir2.1and/or Na+/K+ ATPase can occur with the
source of the "potassium clouds " being the smooth muscle cell s, i.e. as a consequence of
the activation of K+channels that propagate to derive the subsequent events.
Either of the treatment i.e. removal of endothelium or consumption of high salt diet shifts
the Emtoward hyperpolarized state. The change of Emto more negative potential
substantially diminishes the hyperpolarization induced by isoprenaline. This suggests
that there is a ceiling for isoprenaline-induced hyperpol arization i.e. if the tissue is in the
range of EK ; further hyperpolarization with a p-adrenoceptor agonist may not occur .
Consumption of high salt diet has a direct impact on p-adrenoceptor signalling in rat main
pulmonary arterial vessels . This change is not due to pressure nor is it seems to be
dependent on electrolytes but could be due to changes in neurohumoral factors . The
sustained hyperpolarization observed with chronic consumption of a high salt diet
involves the opening of leak channels (TASK) , Kir2.1channels and the activation of
Na+/K+ATPase . This hyperpolarization preserves isoprenaline-evoked relaxant responses
in the main pulmonary artery.
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Stimulation ofp-adrenoce ptors initiates the formation of "potassium cloud" that spread s
along the artery with the aid of endothelium. Endothelium plays a role of conduit for
electrical coupling. The smoot h muscle cell layer has been implica ted as an alternat ive
cond uction pathway in the event of damage to the endothelium (Budel et al., 2003) . Thus
it is possible that in the absence of endothelium attenuates the exte nt of p-adrenoceptor-
mediated relaxant responses . TAS K channels play an important role in p-adrenoceptor s
signalling in rat pulm onary artery . These leak conductances have been shown to be an
important comp onent in regulating pulm onary vasc ular tone (Olschewsk i et al., 20 I0).
This project showe d that the presence of endothelium is necessary for participation of
TAS K in p-adrenoceptor-m ediated responses. Ident ification of these mechanisms
increases our understandin g of the process involved in the blood flow to the organs and
could exp lain how these processes can be compro mised in diseases in which endothelial
functio n is reduced.
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5.0. LIMITAnONS
As with all experim ental designs, a numb er of limitations can be identified with the
present work. For example, it would have been ideal, if memb rane potenti al was
recorded simultaneously with mechanical funct ion for complete concentration-response
curve to isoprenaline. This would allow for greater understandin g of the relationship
between vascular hyperpolarization and relaxati on . Evaluation of TASK express ion on
endothelial and vascular smooth muscle cell s from rats fed either diet (regular or a high
salt diet) cou ld have provided additional evidence for the increased particip ation of the
chann el following high salt consumption. It would be meanin gful to measure the quantit y
of salt con sumed by rats.As well , it would be intere sting to study and comp are the p-
adrenoceptor signalling in smaller vesse ls such as mesentery artery which contributes in
the total peripheral vascul ar resistance in the systemic circulatory bed. To this end, future
experiments could be aimed at investigating the changes in p-adrenoce ptor-mediated
electrical and mechanical responses in systemic blood vesse ls.
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